WO2018033920A1 - Cathéter d'administration de médicament et son procédé d'utilisation - Google Patents

Cathéter d'administration de médicament et son procédé d'utilisation Download PDF

Info

Publication number
WO2018033920A1
WO2018033920A1 PCT/IL2017/050911 IL2017050911W WO2018033920A1 WO 2018033920 A1 WO2018033920 A1 WO 2018033920A1 IL 2017050911 W IL2017050911 W IL 2017050911W WO 2018033920 A1 WO2018033920 A1 WO 2018033920A1
Authority
WO
WIPO (PCT)
Prior art keywords
balloon
catheter
perforated
drug
inner balloon
Prior art date
Application number
PCT/IL2017/050911
Other languages
English (en)
Inventor
Eran VICKOS
Lihu AVITOV
Peter J. Fitzgerald
Eran Harari
Original Assignee
Angioslide Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angioslide Ltd. filed Critical Angioslide Ltd.
Publication of WO2018033920A1 publication Critical patent/WO2018033920A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1002—Balloon catheters characterised by balloon shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1011—Multiple balloon catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M2025/0183—Rapid exchange or monorail catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1002—Balloon catheters characterised by balloon shape
    • A61M2025/1004—Balloons with folds, e.g. folded or multifolded
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1011—Multiple balloon catheters
    • A61M2025/1013—Multiple balloon catheters with concentrically mounted balloons, e.g. being independently inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes

Definitions

  • the present invention in some embodiments thereof, relates to drug delivery catheters and more particularly, but not exclusively, to a drug delivery catheter having an inflatable drug delivering inner balloon and a perforated outer balloon and methods of use thereof.
  • DCB Drug coated balloons
  • DCBs are intended to maintain the native vessel and leave future treatment options open while maximizing the time to first lesion re-intervention.
  • each DCB is comprised of a balloon, coated by an excipient (carrier matrix/polymer/ transfer agents; Polysorbate, Urea and the like) and a drug (Paclitaxel, Rapamycin, and the like).
  • excipient carrier matrix/polymer/ transfer agents; Polysorbate, Urea and the like
  • drug Paclitaxel, Rapamycin, and the like.
  • Different DCBs may differ in the drug dosage, the excipient, coating technology and balloon materials.
  • Drug delivery catheters are well known in the art.
  • Such catheters may be, for example, angioplasty balloon catheters having an angioplasty balloon which is coated with a drug or a formulation or composition of matter containing a drug or a therapeutically active agent
  • Such drugs may include, inter alia, anti-restenosis agents, anti-proliferative agents as well as anti coagulating agents.
  • angioplasty treatment such as opening a constricted atheromatous blood vessel such as an artery or a vein
  • the catheter is inserted into the vasculature and advanced (typically over a guide wire) until the angioplasty balloon is positioned within the constricted region of the blood vessel.
  • the balloon After poisoning the catheter, the balloon is inflated and expanded to open or enlarge or dilate the occluded or constricted (stenotic) region of the vessel, as is known in the art.
  • the balloon When the balloon is inflated, it comes in contact with the inner surface of the blood vessel and may deliver some of the drug or therapeutic composition to the walls of the blood vessel.
  • the delivery may occur mechanically by adherence of some of the drug or therapeutic composition to the intimal layer upon contact with the drug coated outer surface of the balloon or by dissolution or elution of the drug in the blood and diffusion of the drug into the intimal layer where the drug may exert a biologically therapeutic effect reducing or preventing proliferation of the blood vessel epithelial cells and the resulting restenosis of the treated vessel site.
  • a common problem of such prior art drug delivery catheters is that during the insertion of the catheter into the vasculature and the moving of the catheter within the vasculature to reach the treatment site, the drug or therapeutic composition coating the outer surface of the balloon is exposed to the blood contained in the vasculature, which may result in some of the drug or active ingredient in the therapeutic composition to dissolve or become dispersed in the blood before the balloon has reached the desired treatment site.
  • This "washout" effect may be particularly problematic when the drug or active ingredient of the coating formulation is soluble in aqueous media.
  • the drug coated surface of the balloon may come in contact with the walls of the vasculature which may result in mechanically abrading and/or removing some of the coating of the balloon prior to reaching the treatment site.
  • This dissolving of the active ingredient and/or mechanical degradation of the coating layer of the balloon may result in a reduction in the amount of drug or active ingredient which may be delivered to the treated site with concomitant reduction in treatment efficacy.
  • the passage of the balloon through the vasculature may result not only in loss of drug but may also result in releasing flakes or particles of the coating into the blood stream which may adversely affect the treatment's success rate and may even result in an increase a patient mortality rate as compared to standard angioplasty.
  • FIG. 1 is a schematic longitudinal cross sectional view illustrating a drug delivery catheter, in a non-inflated state, in accordance with an embodiment of the drug delivery catheters of the present application;
  • FIG. 2 is a schematic transversal cross sectional view of the catheter of Fig. 1 taken along the lines II- II when the inner balloon of the catheter is in a non-inflated state;
  • FIG. 3 is a schematic transversal cross-section of the catheter of Fig. 1 taken along the lines II- II, when the inner balloon of the catheter is in an inflated state;
  • FIG. 4 is a schematic cross sectional view illustrating part of an OVT drug delivery balloon catheter in an inflated state disposed in a blood vessel, in accordance with an embodiment of the catheters of the present invention
  • FIG. 5 is a schematic longitudinal cross sectional view illustrating a rapid- exchange (RE) drug delivery catheter, in a non-inflated state, in accordance with an embodiment of the drug delivery catheters of the present application;
  • RE rapid- exchange
  • FIG. 6 is a schematic transversal cross sectional view of the catheter of Fig. 5 taken along the lines V-V when the inner balloon of the catheter is in a non-inflated state;
  • FIG. 7 is a schematic transversal cross-sectional view taken along the lines V-V of Fig. 5, illustrating the catheter of Fig. 5 when the inner balloon of the catheter is in an inflated state;
  • FIGs. 8 and 9 are schematic transversal cross- sectional views illustrating a drug delivery catheter having a folded inner balloon and a non-folded perforated outer balloon in an non-inflated state and an inflated state, respectively, in accordance with some embodiments of the catheters of the present application;
  • FIGs. 10 and 11 are a schematic transversal cross-sectional views illustrating a drug delivery catheter having a folded inner balloon and a folded perforated outer balloon, in an non-inflated state and an inflated state, respectively, in accordance with some embodiments of the catheters of the present application;
  • FIGs. 12-13 are a schematic transversal cross- sectional views illustrating a drug delivery catheter having a non-folded inner balloon and a folded perforated outer balloon, in an non-inflated state and an inflated state, respectively, in accordance with some embodiments of the catheters of the present application;
  • FIGs. 14-16 are a schematic longitudinal cross- sectional views illustrating three different drug delivery catheter parts having three different configurations of attachment of the inner and outer balloons to the catheter, in accordance with some embodiments of the catheters of the present application;
  • FIG.17 is a schematic side view illustrating part of an assembled drug delivery catheter, in accordance with an embodiment of the catheters of the present application.
  • FIG. 18 is a schematic front view of the catheter of Fig. 17 as viewed in the direction indicated by the arrow F;
  • FIG. 19 is a schematic side view of the outer perforated balloon of the catheter of Fig. 17;
  • FIG. 20 is a schematic side view of the shaft and the inner drug coated balloon of the catheter of Fig. 17;
  • FIG. 21 is a schematic isometric view illustrating the assembled catheter part of Fig.
  • FIG. 22 is a schematic longitudinal cross sectional view illustrating a rapid exchange (RE) drug delivery catheter having a catheter shaft including an outer conduit and an inner conduit, in accordance with an embodiment of the drug delivery catheters of the present application;
  • RE rapid exchange
  • FIG. 23 is a schematic longitudinal cross sectional view illustrating an "over the wire” (OVT) drug delivery catheter having a catheter shaft including an outer conduit and an inner conduit, in accordance with an embodiment of the drug delivery catheters of the present application
  • FIG. 24 is a schematic cross sectional view illustrating part of an OVT drug delivery balloon catheter, having a conically shaped inflatable inner balloon and a conically shaped perforated outer balloon, in accordance with an embodiment of the catheters of the present application;
  • FIG. 25 is a schematic cross sectional view illustrating part of an OVT drug delivery balloon catheter having stepped inner and outer balloons illustrated in an inflated state, in accordance with an embodiment of the catheters of the present application.
  • a catheter for delivering a drug includes a shaft having an outer surface, an inflatable inner balloon sealingly attached to the shaft, the inflatable inner balloon has an outer surface and at least a portion of the outer surface is coated with a drug or a composition comprising a drug.
  • the catheter also includes a perforated outer balloon sealingly attached to the shaft and/or to the inner balloon.
  • the outer perforated balloon surrounds the inflatable inner balloon.
  • the outer perforated balloon includes a plurality of perforations formed in at least a portion of the perforated outer balloon.
  • the shaft is a double lumen hollow shaft having a first lumen for inserting a guide wire there through and a second lumen for passing inflation fluid there through for inflating the inflatable inner balloon.
  • the catheter is configured as an "over the wire” (OVT) catheter and the first lumen has a proximal opening at a proximal end of the catheter and a distal opening at the distal end of the catheter for passing the catheter over a guide wire.
  • OPT over the wire
  • the catheter is configured as a rapid exchange (RE) catheter and the first lumen has an opening disposed on the shaft at a position located between the proximal end of the catheter and the proximal end of the perforated outer balloon.
  • the first lumen has a second opening at the distal end thereof for passing the catheter over a guide wire.
  • a proximal end of the inflatable inner balloon is sealingly attached to a first region of the outer surface of the shaft, and the distal end of the inflatable inner balloon is sealingly attached to a second region of the outer surface of the shaft.
  • a proximal end of the perforated outer balloon is sealingly attached to a third region of the outer surface of the shaft and a distal end of the perforated outer balloon is sealingly attached to a fourth region of the outer surface of the shaft.
  • the third region is disposed on the outer surface of the shaft proximal to the first region and the fourth region is disposed on the outer surface of the shaft distal to the second region.
  • a proximal end of the perforated outer balloon is sealingly attached to the proximal end of the inflatable inner balloon and a distal end of the perforated outer balloon is sealingly attached to the distal end of the inflatable inner balloon.
  • a proximal end of the perforated outer balloon is sealingly attached to the proximal end of the inflatable inner balloon and a distal end of the perforated outer balloon is sealingly attached to a third region of the outer surface of the shaft.
  • the third region is disposed on the outer surface of the shaft distal to the second region.
  • a distal end of the perforated outer balloon is sealingly attached to the distal end of the inflatable inner balloon and a proximal end of the perforated outer balloon is sealingly attached to the outer surface of the shaft at a third region of the outer surface of the shaft.
  • the third region is disposed on the outer surface proximal to the first region.
  • the shaft comprises a hollow outer conduit having a first lumen and a hollow inner conduit disposed within the first lumen.
  • the inner conduit has a second lumen suitable for passage over a guide wire.
  • the inner conduit is fixed relative to the outer conduit and is longitudinally unmovable within the second lumen of the inner conduit. A portion of a distal end of the inner conduit protrudes beyond the distal end of the outer conduit.
  • the catheter is configured as an "over the wire” (OVT) catheter in which the second lumen of the inner conduit has a first opening disposed at a proximal end of the shaft and a second opening disposed at the distal end of the catheter, for passing the second lumen over a guide wire.
  • OPT over the wire
  • the catheter is configured as a rapid exchange (RE) catheter.
  • the proximal end of the inner conduit is bent and is sealingly attached to a region of wall of the outer conduit such that the second lumen has a first opening disposed on an outer surface of the outer conduit at a position located between the proximal end of the catheter and the proximal end of the perforated outer balloon.
  • the second lumen has a second opening disposed at a distal end of the inner conduit for passing the second lumen of the inner conduit over a guide wire.
  • a proximal end of the inflatable inner balloon is sealingly attached to a first region of an outer surface of the distal end of the outer conduit and a distal end of the inflatable inner balloon is sealingly attached to a second region of an outer surface of the portion of the distal end of the inner conduit that protrudes beyond the distal end of the outer conduit.
  • a proximal end of the perforated outer balloon is sealingly attached to a third region of the outer surface of the distal end of the outer conduit and a distal end of the perforated outer balloon is sealingly attached to a fourth region of the outer surface of the portion of the inner conduit that protrudes distally beyond the distal end of the outer conduit.
  • the third region is disposed on the outer surface of the outer conduit proximal to the first region and the fourth region is disposed on the outer surface of the inner conduit distal to the second region.
  • a proximal end of the perforated outer balloon is sealingly attached to the proximal end of the inflatable inner balloon and a distal end of the perforated outer balloon is attached to the distal end of the inflatable inner balloon.
  • a proximal end of the perforated outer balloon is sealingly attached to the proximal end of the inflatable inner balloon and a distal end of the perforated outer balloon is sealingly attached to a third region of the outer surface of the inner conduit, the third region is disposed on the outer surface of the portion of the inner conduit that protrudes distally beyond the distal end of the outer conduit distal to the second region.
  • a distal end of the perforated outer balloon is sealingly attached to the distal end of the inflatable inner balloon and a proximal end of the perforated outer balloon is sealingly attached to the outer surface of the outer conduit at a third region of the outer surface of the outer conduit, the third region is disposed on the outer surface of the outer conduit proximal to the first region.
  • the inner inflatable balloon is selected from, a substantially cylindrically shaped balloon, a substantially conically shaped balloon and a stepped balloon.
  • the perforated outer balloon is selected from a substantially cylindrically shaped balloon, a substantially conically shaped balloon and a stepped balloon.
  • the drug or composition comprising a drug includes one or more of a therapeutic substance, a diagnostic substance, a drug, a therapeutic composition, a medicament, a diagnostic composition, a physiologically active agent, a biochemically active agent, one or more living cells, DNA, RNA, a nucleic acid, a vector for delivering genetic material to cells in the treated site, an anti-inflammatory agent, an anti-restenosis agent, a cell proliferation inhibitory agent, a smooth muscle proliferation inhibiting agent, paclitaxel, rapamycin, everolimus, a vaso-active agent, a vaso dilating agent, a vaso constricting agent, an antibiotic agent, an anti-coagulative agent, a platelet aggregation inhibiting agent, an anti-fibrosis agent, a pharmaceutically acceptable vehicle, a lipid based vehicle, and any combinations thereof.
  • the drug or the composition comprising a drug are encapsulated is a drug carrier system selected from a nanoparticle based carrier system and liposomes.
  • the perforated outer balloon comprises a material selected from a compliant material, a semi-compliant material, a non-compliant material, a stretchable material, a non-stretchable material, an annealed stretchable material, a pre-stretched non-stretchable material that has undergone molecular orienting by biaxial orienting processes, and any combinations thereof.
  • the inflatable inner balloon comprises a material selected from a compliant material, a semi-compliant material, a non-compliant material, a stretchable material, a non-stretchable material, an annealed stretchable material, a pre-stretched non-stretchable material that has undergone molecular orienting by biaxial orienting processes, and any combinations thereof.
  • the perforated outer balloon comprises a material selected from a polymer based material, Nylon ® Nylon 12 ® , PET, a polyamide PA12, Grilamid ® L25, Grilamid ® L55, PA11, Polyether block amides PEBAX ® 7233, PEBAX ® 7033, PEBAX ® 6333), Grilflex ® ELG 6260, Polyester, polyethylene, polyurethane and any combinations thereof.
  • the inflatable inner balloon comprises a material selected from a polymer based material, Nylon ® Nylon 12 ® , PET, a polyamide PA12, Grilamid ® L25, Grilamid ® L55, PA11, Polyether block amides PEBAX ® 7233, PEBAX ® 7033, PEBAX ® 6333), Grilflex ® ELG 6260, Polyester, polyethylene, polyurethane and any combinations thereof.
  • the inflatable inner balloon and the perforated outer balloon are arranged in an arrangement selected from: 1) The inner balloon is not folded and the outer balloon is not folded, 2) The inner balloon is not folded and the outer balloon is folded over the inner balloon, 3) The inner balloon is folded over the shaft and the outer balloon is not folded, and 4) The inner balloon is folded over the shaft and the outer balloon is folded over the inner balloon.
  • the outer perforated balloon prior to inflation of the inner balloon, is folded over the inner balloon and at least some perforations of the plurality of perforations of the perforated outer balloon are disposed within one or more folds of the outer perforated balloon.
  • inflating the inflatable inner balloon results in stretching of the outer perforated balloon and increasing the area of the plurality of perforations. Furthermore, in accordance with some embodiments of the catheter, inflating the inflatable inner balloon causes portions of the outer surface of the inner inflatable balloon to curve and protrude from the plurality of perforations.
  • a method of delivering a drug to a treatment site in a body cavity using the drug delivery catheters described hereinabove includes the steps of inserting the drug delivery catheter into a body cavity to dispose the perforated outer balloon in a treatment site and inflating the inflatable balloon to treat the site and to deliver at least some of the drug to at least some regions of the treatment site through at least some perforations of the plurality of perforations.
  • the catheter also includes a stent disposed on the perforated outer balloon and the step of inflating also includes expanding and deploying the stent in the treatment site.
  • the body cavity is a blood vessel and the treated region is selected from an atheroma, a plaque and a stenosed region of the blood vessel.
  • the outer perforated balloon of the catheter is a stretchable balloon and the step of inflating also comprises stretching the perforated outer balloon to increase the area of the plurality of perforations.
  • the step of inflating also includes the step of causing at least some portions of the inflated drug coated inner balloon to protrude through the plurality of perforations beyond an outer surface of the outer perforated balloon and to contact at least some portions of the treatment site for facilitating transfer of the drug to the treatment site.
  • the outer perforated balloon prior to the step of inflating, is folded over the inner inflatable balloon and the step of inflating also includes the step of unfolding and expanding the outer perforated balloon.
  • the inflatable inner balloon is folded and the step of inflating also includes the step of unfolding and expanding the inner balloon. Furthermore, in accordance with some embodiments of the method, the inflatable inner balloon is a folded balloon and the step of inflating also includes the step of unfolding the folded inner balloon.
  • the perforated outer balloon is not folded and is a stretchable balloon and the step of inflating also includes the step of expanding the stretchable perforated outer balloon.
  • the method also includes, prior to the step of inflating, the step of protecting by the perforated outer balloon a drug coated on an outer surface of the inflatable inner balloon.
  • At least the perforated outer balloon is a folded balloon having folds
  • the method also includes the step of protecting by the folds of the folded perforated outer balloon at least some perforations of the plurality of perforations from penetration of blood or a body fluid, during the step of inserting.
  • the drug- delivering catheter is selected from an over the wire (OVT) catheter and a rapid exchange (RE) catheter and wherein the step of inserting comprises inserting the catheter into the body cavity over a guide wire.
  • OPT over the wire
  • RE rapid exchange
  • the drug or composition comprising a drug coating the outer surface of the inflatable inner balloon includes one or more of a therapeutic substance, a diagnostic substance, a drug, a therapeutic composition, a medicament, a diagnostic composition, a physiologically active agent, a biochemically active agent, one or more living cells, DNA, RNA, a nucleic acid, a vector for delivering genetic material to cells in the treated site, an anti- inflammatory agent, an anti-restenosis agent, a cell proliferation inhibitory agent, a smooth muscle proliferation inhibiting agent, paclitaxel, rapamycin, everolimus, a vasoactive agent, a vaso dilating agent, a vaso constricting agent, an antibiotic agent, an anti-coagulative agent, a platelet aggregation inhibiting agent, an anti-fibrosis agent, a pharmaceutically acceptable vehicle, a lipid based vehicle, and any combinations thereof.
  • the method also includes the step of inserting a medical device and/or a diagnostic device through a lumen formed in the catheter shaft.
  • the present invention in some embodiments thereof, relates to drug delivery catheters and more particularly, but not exclusively, to a drug delivery catheter having a perforated outer balloon and methods of use thereof.
  • compositions, method or structure may include additional ingredients, steps and/or parts, but only if the additional ingredients, steps and/or parts do not materially alter the basic and novel characteristics of the claimed composition, method or structure.
  • a compound or “at least one compound” may include a plurality of compounds, including mixtures thereof.
  • range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible sub-ranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed sub ranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 3, 4, 5, and 6. This applies regardless of the breadth of the range.
  • drug coated balloon and its conjugates means a balloon having an outer surface to which an amount of drug or drug containing formulation or a drug containing mixture of substances has been applied or added.
  • the drug may be coated onto the outer surface of the balloon or may be applied to the outer surface of the balloon by any other suitable method known in the art.
  • the word “coated” is not used in a limited sense and should be construed to broadly mean also that the drug has been added or applied or adhered to the balloon using any method of application known in the art.
  • drug coated surface any surface or balloon which may be either coated with or covered with or otherwise includes or comprises either a single drug or a mixture of multiple drugs or a material composition including one or more drugs or biologically active agents, with or without a suitable carrier and/or excipient.
  • Such compositions may also include any drug-releasing matrix or substance formulated to carry one or more drugs or biologically active agents therein, as is well known in the art of drug delivery catheters.
  • drug is not intended to restrict the scope of the above terms to a single drug only but means one or more drugs or one or more active agents with or without other substances and/or matrices and/or drug carriers and/or drug containing liposomes and/or any combinations thereof.
  • the above terms are also intended to include drugs and/or compositions of matter that may be in a solid form, in a liquid form, in a gel form or in any other suitable form for carrying and delivering one or more biologically active agents to a treated region of the vasculature, as is well known in the art of drug delivering catheters.
  • Implementation of the method and/or system of embodiments of the invention can involve performing or completing selected tasks manually, automatically, or a combination thereof.
  • Load is defined as the force or pressure acting on a component (such as an inner balloon, an outer perforated balloon, and a lumen of a catheter shaft).
  • “Stretchable” - is used to define a component or structure or material that changes its shape or dimensions permanently after application of load (such as increase of diameter) by at least 10% of its original size and is deformed plastically under a working load.
  • Non-stretchable is used to define a component or structure or material that does not permanently change its shape or dimensions after application of load by more than 10 % of its original size or dimension.
  • “Compliant” - is used to define a component or structure or material that reversibly changes shape or dimension after application of load (such as an increase of diameter, and/or length, and the like) by at least 15% of its original size or dimension and is deformed super-elastically (in a rubber-like manner under a working load).
  • “Semi-Compliant” - is used to define a component or structure or material that reversibly changes its shape or dimension after application of load (such as increase of diameter) in the range of 2%- 15% of its original size or dimension and is deformed elastically under a working load).
  • Non-Compliant - is used to defined a component or structure or material that reversibly changes its shape or dimension after application of load (such as increase of diameter or length, and the like) by 0% - 2% of its original size or dimension and is either not deformed or is deformed elastically under a working load, within the above indicated range.
  • PEBAX 5533 is a material with mechanical properties similar (but not identical) to a hard but non- vulcanized rubber.
  • TABLE 1 the following shorthand denotations are used to represent the following mechanical properties:
  • NS - represents " Non-Stretchable”.
  • SC - represents "Semi-Compliant".
  • NC - represents "Non-Compliant".
  • distal side of a catheter is denoted by the letter D and the proximal side of a catheter is denoted by the letter P.
  • An arrow associated with the letter D points towards the distal direction and an arrow associated with the letter P points at the proximal direction.
  • This directional notation is also used to indicate the distal and proximal sides or ends of other components of the catheters disclosed in the present application.
  • Fig. 1 is a schematic longitudinal cross sectional view illustrating a drug delivery catheter, in a non-inflated state, in accordance with an embodiment of the drug delivery catheters of the present application.
  • Fig. 1 the distance between the outer surface 2C of the shaft 2 and the inner surface 4D of the inner balloon 4 as well as the distance between the outer surface 4C of the inner balloon 4 and the inner surface 6D of the balloon 6 are somewhat exaggerated in Fig. 1 for the sake of clarity of illustration (in order to clearly discern the different parts and portions of the inner balloon 4 and the outer balloon 6).
  • some parts or portions of the inner surface 4D of the inner balloon 4 may be in contact with the outer surface 2C of the shaft 2 and some parts or portions of the inner surface 6D of the outer balloon 6 may be in contact with the outer surface 4C of the inner balloon 4.
  • the catheter 10 is configured as an "over the wire” (OVT) catheter.
  • the catheter 10 includes a hollow shaft 2, an inner balloon 4 and a perforated outer balloon 6.
  • the shaft 2 may be a double lumen hollow shaft having a first lumen 2A for passing the catheter 10 over a guide wire 3, and a second lumen 2B for passing inflation fluid there through for inflating the inner balloon 4.
  • the shaft 2 (or any of the other shafts disclosed in the present application may be made of or may include materials such as, but not limited to, a biocompatible thermoplastic polymer, Nylon ® , Pebax ® , polyurethane,
  • PET Polyethyleneterephtalate
  • stainless steel any other suitable material.
  • the outer perforated balloon 6 of the catheter 10 may be made of or may include a material selected from a polymer based material, Nylon ® Nylon 12 ® , PET, a polyamide PA12, Grilamid ® L25, Grilamid ® L55, PA11, Polyether block amides PEBAX ® 7233, PEBAX ® 7033, PEBAX ® 6333), Grilflex ® ELG 6260, Polyester, polyethylene, polyurethane, and any combinations thereof.
  • the proximal end 4 A of the inner balloon 4 is sealingly attached to a first region of the outer surface 2C of the shaft 2 and the distal end 4B of the inner balloon 4 is sealingly attached to a second region of the outer surface 2C of the shaft 2.
  • the proximal and distal end 4 A and 4B, respectively, of the inner balloon 4 may be sealingly attached to the outer surface 2C by gluing or welding or thermal bonding or ultrasonic welding or by any other suitable attachment method as is known in the art.
  • the outer surface 4C of the inner balloon 4 is coated or covered with a layer of a drug or a layer of a material composition or therapeutic formulation or therapeutic composition comprising one or more drugs and/or active agents, and/or active ingredient(s) as is well known in the art (it is noted that, in all of the drawing figures the catheter embodiments disclosed in the present application, the layer of drug or composition coating the outer surface of the inner balloons is not shown, for the sake of clarity of illustration).
  • the coating the inner balloons of the drug delivery balloon catheters of the present application may include, but are not limited to, one or more of a therapeutic substance, a diagnostic substance, a drug, a therapeutic composition, a medicament, a diagnostic composition, a physiologically active agent, a biochemically active agent, one or more living cells, DNA, RNA, a nucleic acid, a vector for delivering genetic material to cells in the treated site, an anti-inflammatory agent, an anti-restenosis agent, a cell proliferation inhibitory agent, a smooth muscle proliferation inhibiting agent, paclitaxel, rapamycin, everolimus, a vaso-active agent, a vaso dilating agent, a vaso constricting agent, an antibiotic agent, an anti-coagulative agent, a platelet aggregation inhibiting agent, an anti-fibrosis agent, a pharmaceutically acceptable vehicle, a lipid based vehicle, and
  • any drug or biologically active substance that are included in the drug delivery catheters of the present invention including but not limited to any of the substances and compositions disclosed hereinabove may be encapsulated in nanoparticle carrier systems and/or in liposomes, as is well known in the art.
  • the lumen 2B of the shaft has an opening 2D that opens into the lumen 4E of the inner balloon 4.
  • a proximal connecting member 15 is suitably sealingly attached to the proximal end of the shaft 2.
  • the proximal connector member 15 includes a hollow guide wire port 15A and a hollow inflation port 15B.
  • the Lumen 2B may be used for inflating the inner balloon 4 by injecting a suitable inflation fluid through a suitable opening 5 at the end of the inflation port 15B.
  • the hollow inflation port is in fluidic communication with the lumen 2B of the shaft 2 and through the lumen 2B and the opening 2D and with the lumen 4E of the inner balloon 4.
  • the inflation of the inner balloon 4 may be performed by connecting the inflation port 15 to a suitable indeflator (not shown in Fig.
  • the catheter 10 also includes a soft tip 9 attached to the distal end of the shaft 2.
  • the soft tip 9 may be a tapered member made of a soft resilient material.
  • the soft tip 9 may be shaped as a hollow conical or frusto-conical tip but other shapes such as, but not limited to a hollow rounded open cap (not shown) may also be used if desired.
  • the soft tip 9 may be made from a soft pliable material, such as but not limited to PEBAX 5533, PEBAX 6333, a soft thermoplastic polyurethane (TPU), a thermoplastic silicone-urethane copolymer (TSUC), or other suitable soft and/or pliable materials.
  • TPU soft thermoplastic polyurethane
  • TSUC thermoplastic silicone-urethane copolymer
  • the material of the soft tip 9 may include a radio-opaque filler, such as but not limited to, barium sulphate (BaS0 4 ) or the like.
  • a radio-opaque filler such as but not limited to, barium sulphate (BaS0 4 ) or the like.
  • Such radio-opaque filler-including soft tip may be used as a radio-opaque marker indicating the approximate position of the distal balloon end when viewed using angiographic methods to position the catheter.
  • the soft tip 9 is a hollow tip having a passage 9A passing there through.
  • the passage has an orifice 9B which opens at the distal end of the soft tip 9.
  • the soft tip 9 may be glued or bonded or otherwise fixedly or detachably attached to the distal end of the shaft 2 (such as, but not limited to, by gluing, bonding, thermal bonding, or by mounting without bonding and the like).
  • a guide wire 3 may be inserted into a proximal opening 8 disposed in a hollow guide wire insertion port 15A included in the connector member 15 at the proximal end of the catheter 10.
  • the guide wire 3 may pass through the hollow passage 2A of the shaft 2 and through the passage 9A of the soft tip 9 and may exit from the orifice 9B at the distal end of the soft tip 9 as illustrated in Fig. 1.
  • the soft tip 9 facilitates passage of the catheter 10 through bending or tortuous bodily passages or blood vessels, without excessively damaging or injuring the walls of the bodily passage or of the blood vessel.
  • the soft tip 9 is optional and the catheters disclosed in the present application may be constructed and used without such a soft tip.
  • the outer balloon 6 surrounds the inner balloon 4 for protecting the drug coated outer surface 4C of the inner balloon 4.
  • the outer balloon 6 has multiple perforations 6F therein.
  • the perforations 6F may be multiple openings formed in the wall of the outer balloon6.
  • the perforations 6F in the specific exemplary embodiment illustrated in Figs 1-2, are circular perforations arranged in six substantially parallel rows of perforations along the length of the outer balloon 6.
  • the perforations may have other non-circular opening shapes, such as, for example, elliptical openings, square openings, elongated openings, slot-like openings, or any other suitable shapes of openings.
  • Such openings may or may not be arranged in longitudinal rows and the number of rows (if used) may be any suitable number in the range of 2- 30 rows (but a number of rows higher than 30 may also be used in some embodiments), depending, inter alia, on the size of the openings, the physical properties of the material(s) from which the outer balloon 6 is made, the type and chemical/physical characteristics of the drug or therapeutic composition attached to the outer surface 4C of the inner balloon 4 and the particular application of the catheter.
  • the number of perforations in a row may depend, inter alia, on the length of the outer balloon 6, the size of the openings, the physical properties of the material(s) from which the outer balloon 6 is made, the type and chemico-physical characteristics of the drug or therapeutic composition attached to the outer surface 4C of the inner balloon 4 and the particular application of the catheter. It is noted that the perforation diameter (for circular perforations 6F) or the perforation's area (for non-circular perforations 6F) may (optionally) become larger when the inner balloon 4 is inflated, depending, inter alia, on the degree of compliance of the material from which the outer balloon 6 is made as is disclosed in detail hereinafter.
  • the outer balloon 6 has a proximal end 6A and a distal end 6B.
  • the length of the outer balloon 6 may (optionally) be larger than the length of the inner balloon 4.
  • the proximal end 6A of the outer balloon 6 is sealingly attached to a third region of the outer surface 2C of the shaft 2 and the distal end 6B of the outer balloon 6 is sealingly attached to a fourth region of the outer surface 2C of the shaft 2.
  • the proximal and distal end 6 A and 6B, respectively, of the outer balloon 6 may be sealingly attached to the outer surface 2C by gluing or welding or thermal bonding or ultrasonic welding or by any other suitable attachment method as is known in the art.
  • the third region of the surface 2C to which the proximal end 6A of the outer balloon 6 is sealingly attached may be located on the surface 2C proximal to the location of the third region of the surface 2C to which the proximal end 4A of the inner balloon 4 is sealingly attached.
  • the fourth region of the surface 2C to which the distal end 6B of the outer balloon 6 is sealingly attached may be located on the surface 2C distal to the location of the second region of the surface 2C to which the distal end 4B of the inner balloon 4 is sealingly attached.
  • the length of the outer balloon 6 may be either equal to or shorter than the length of the inner balloon 4.
  • the proximal end of the outer balloon may be sealingly attached directly to the outer surface of the proximal end of the inner balloon and the distal end of the outer balloon may be sealingly attached directly to the outer surface of the distal end of the inner balloon.
  • Fig. 2 is a schematic transversal cross section of the catheter of Fig. 1 taken along the lines II- II when the inner balloon of the catheter is in a non-inflated state.
  • Fig. 3 is a schematic transversal cross-section of the catheter of Fig. 1 taken along the lines II-II, when the inner balloon of the catheter is in an inflated state.
  • Fig. 2 the inner balloon 4 is illustrated in a non-inflated state. It is noted that the distance between the outer surface 2C of the shaft 2 and the inner surface 4D of the inner balloon 4 as well as the distance between the outer surface 4C of the inner balloon 4 and the inner surface 6D of the balloon 6 are somewhat exaggerated for the sake of clarity of illustration. In some embodiments of the catheters of the present application, some parts or portions of the inner surface 4D of the inner balloon 4 may be in contact with the outer surface 2C of the shaft 2 and some parts or portions of the inner surface 6D of the outer balloon 6 may be in contact with the outer surface 4C of the inner balloon 4.
  • the inner balloon 4 when the inner balloon 4 is inflated with inflation fluid at the nominal inflation pressure, the inner balloon 4 may expand to an inflated state.
  • the inner balloon 4 is made from a compliant material or a semi-compliant material (see detailed definitions and TABLE 1, hereinafter), the cross-sectional area (or the mean diameter) of the inner balloon 4 in the inflated state may be substantially larger than the cross-sectional area (or the mean diameter) of the inner balloon 4 in the non- inflated state as illustrated in Fig. 3.
  • the outer balloon 6 may also expand radially such that the cross-sectional area (or the mean diameter) of the outer balloon 6 after inflation of the inner balloon 4 is larger than the cross-sectional area (or the mean diameter) of the outer balloon 6 before inflation of the inner balloon 4.
  • the parts or portions of the inner balloon 4 which face the perforations 6F may expand to form convex regions 4K, 4L, 4M, 4N, 4P and 4Q which bulge radially and may extend beyond of the perforations 6F as illustrated in Fig. 3.
  • part of the drug coated surface of the convex regions 4K, 4L, 4M, 4N, 4P and 4Q may come in contact with the blood vessel wall (not shown in Fig. 3) or with the wall of any other bodily passage within which the catheter 10 is disposed.
  • the contact between the bulging convex regions 4K, 4L, 4M, 4N, 4P and 4Q may assist in the delivery of drug or active ingredient(s) from the composition coating or attached to the convex regions 4K, 4L, 4M, 4N, 4P and 4Q to portions of the wall of the treated blood vessel or other body passage being treated.
  • the inner balloon 4 may be made from a compliant or semi-compliant material and the outer balloon 6 may made from a semi-compliant material or from a non-compliant material. Therefore, after the inner balloon 4 is inflated at the nominal inflation pressure, the area of the perforations 6F may remain the same (or may increase very slightly) relative to the area of the perforations before the inflation of the inner balloon because the outer balloon 6 may either slightly expand radially due to the pressure exerted thereon by the expanding inner balloon 4 in the case in which the outer balloon is semi-compliant, or may not expand radially or only negligibly expand radially in the case in which the outer balloon 6 is non-compliant.
  • the elasticity of the outer balloon 6 may result in a substantial radial expansion (elastic radial stretching) of the outer balloon 6 in response to the inflation of the inner balloon 4 at the nominal inflation pressure.
  • This elastic stretching and increase in the cross- sectional area of the compliant outer balloon 6 may result in a substantial increase of the area of the perforations 6F of the outer balloon 6 relative to the area of the perforations 6F before the inflation of the inner balloon 4.
  • the perforations 6F may have a relatively small area in the non-expanded state of the outer balloon 6 that may advantageously provide improved covering and protection of the drug coated surface 4C of the inner balloon 4.
  • the area of the perforations 6F advantageously increases, which may substantially increase the total area of the drug coated surface of the inner balloon 4 that contacts the treated region for delivering the drug.
  • Fig. 4 is a schematic cross sectional view illustrating part of an OVT drug delivery balloon catheter in an inflated state disposed in a blood vessel, in accordance with an embodiment of the catheters of the present invention.
  • the shaft 2, the soft tip 9 of the catheter 20 and the guide wire 3 are similar to those of the catheter 10 of Fig. 1.
  • the catheter 20 includes an inner balloon 14 and an outer balloon 16.
  • the proximal end 14A of the inner balloon 14 is sealingly attached to a first region of the outer surface 2C of the shaft 2 and the distal end 14B of the inner balloon 14 is sealingly attached to a second region of the outer surface 2C of the shaft 2.
  • the proximal and distal end 14A and 14B, respectively, of the inner balloon 14 may be sealingly attached to the outer surface 2C by gluing or welding or thermal bonding or ultrasonic welding or by any other suitable attachment method as is known in the art.
  • the outer surface 14C of the inner balloon 4 may be coated or covered with a layer of a drug or a layer of a material composition or therapeutic formulation or therapeutic composition comprising one or more drugs and/or active agents, and/or active ingredients as is disclosed in detail for the inner balloon 4 of Fig. 1.
  • the inner balloon 14 is enclosed within the perforated outer balloon 16 that surrounds the inner balloon 14.
  • the inner balloon 14 of the catheter 20 When the inner balloon 14 of the catheter 20 is inflated (by introducing an inflation fluid at a nominal inflation pressure into the lumen 2B of the shaft 2), the inner balloon 14 is inflated by the inflation fluid entering (in the direction illustrated by the arrow 13) through the opening 2D into the lumen of the balloon 14.
  • the inner balloon 14 may be made from a compliant material or a semi-compliant material and the perforated outer balloon semi compliant 16 may be made from a non-compliant, semi compliant or compliant material.
  • the perforations 16F of the perforated outer balloon 16 are arranged in multiple rows along the length of the outer balloon 16 with each row having four perforations 16F.
  • portions 14K, 14L, 14M and 14N of the balloon 14 convexly protrude through the four perforations 16F of the row of perforations illustrated in the cross- sectional view of Fig. 4 such that the drug coated convex surface of the portions 14K, 14L, 14M and 14N may come in contact with portions of the surface 12 of the plaque (or atheroma) 11 being treated by the catheter 20.
  • the contact between the drug coated surface of the portions 14K, 14L, 14M and 14N with portions of the surface 12 of the plaque 11 may deliver part of the drug to the treated blood vessel. It is noted that while in the exemplary catheter 20 of Fig.
  • the rows of perforations 16F of the perforated balloon 16 each include four perforations, this is by no means obligatory, and in some embodiments of the catheter the number of perforations in a longitudinal row may be larger or smaller than four. Furthermore, the perforations in the perforated outer balloons of the catheters of the present applications need not obligatorily be arranged in rows. In accordance with some embodiments of the catheters of the present application, the perforations of the perforated outer balloon of the catheter may be randomly arranged on the surface of the perforated outer balloon, preferably (but not obligatorily) such that the mean number of perforations per unit area of the surface of the balloon is constant along the surface of the outer perforated balloon.
  • any type of arrangement of the perforations on the surface of the outer perforated balloon may be implemented, including but not limited to, linear rows of perforations, a single helical arrangement or multiple helical arrangements of perforations or any other uniform or non-uniform arrangement of perforations on the surface of the outer perforated balloon.
  • the total number of perforations in the perforated outer balloons of the drug delivery catheters of the present application may depend, inter alia, on the total surface area of the outer balloon, the perforations' diameter (for circular perforations) or the perforations' area (for non-circular perforations), the compliance of the outer balloon and the wall thickness of the outer balloon, and the mechanical properties of the material(s) from which the outer balloon is made.
  • Fig. 5 is a schematic longitudinal cross sectional view illustrating a rapid exchange drug delivery catheter, in a non-inflated state, in accordance with an embodiment of the drug delivery catheters of the present application.
  • the catheter 30 is configured as a rapid exchange (RE) catheter.
  • the catheter 30 includes a hollow shaft 22, an inner balloon 24 and a perforated outer balloon 26.
  • the shaft 22 may be a double lumen hollow shaft having a first lumen 22A for passing the catheter 30 over a guide wire 3, and a second lumen 22B for passing inflation fluid there through for inflating the inner balloon 243.
  • the guide wire 3 may be inserted into the first lumen 22A through an opening 22G of the first lumen 22A.
  • the opening 22G is disposed on the shaft 22 at a position located between the proximal end of the catheter and the proximal end 26 A of the outer perforated balloon 26.
  • the shaft 22 may be made from, or may include flexible materials, as disclosed in detail hereinabove for the shaft 2 of Fig. 1.
  • the proximal end 24A of the inner balloon 24 may be sealingly attached to a first region of the outer surface 22C of the shaft 22 and the distal end 24B of the inner balloon 24 may be sealingly attached to a second region of the outer surface 22C of the shaft 22.
  • the proximal and distal ends 24A and 24B, respectively, of the inner balloon 24 may be sealingly attached to the outer surface 22C by gluing or welding or thermal bonding or ultrasonic welding or by any other suitable attachment method as is known in the art and as disclosed hereinabove.
  • the outer surface 24C of the inner balloon 24 is coated with or covered with a layer of a drug or a layer of a material composition or therapeutic formulation or therapeutic composition comprising one or more drugs and/or active agents, and/or an active ingredients as is well known in the art and as disclosed in detail hereinabove for the inner balloon 4 of Figs. 1-3.
  • the lumen 22B of the shaft has an opening 22D that opens into the lumen 24E of the inner balloon 24.
  • the Lumen 22B may be used for inflating the inner balloon 24 by injecting a suitable inflation fluid through a suitable inflation port 25 attached at the proximal part of the shaft 22 and fluidically connected to the second lumen 22B and through the second lumen 22B to the lumen 24E of the inner balloon 24.
  • the inflation of the inner balloon 24 may be performed by connecting the inflation port 25 to a suitable indeflator (not shown in Fig. 5) as is well known in the art of angioplastic balloon catheters.
  • a sealing plug member 27 that is sealingly attached within the distal end of the second lumen 22B.
  • the catheter 30 may also (optionally) include a soft tip 9 attached to the distal end of the shaft 22 which may be similar in construction and implementation to the soft tip 9 of the catheter 10 of Fig. 1 hereinabove.
  • the outer balloon 26 surrounds the inner balloon 24 for protecting the drug-coated surface of the inner balloon 24.
  • the outer balloon 26 has multiple small perforations 26F therein.
  • the perforations 26F may be multiple openings formed in the wall of the outer balloon 26.
  • the perforations 26F may be circular perforations arranged in multiple rows of perforations along the length of the outer balloon 26.
  • the perforations may have other non-circular opening shapes, such as, for example, elliptical openings, square openings, elongated openings, slot-like openings, or any other suitable shapes of openings.
  • the perforations 26F may or may not be arranged in longitudinal linear rows and the number of rows (if used) may be any suitable number in the range of 2- 50 rows, depending, inter alia, on the size of the openings, the physical properties of the material(s) from which the outer balloon 26 is made, the type and chemical/physical characteristics of the drug or therapeutic composition attached to the outer surface 24C of the inner balloon 24 and the particular application of the catheter.
  • the arrangement of the perforations may be irregular or random, or in accordance with any of the types of perforation arrangements disclosed hereinabove for the catheters 10 and 20.
  • the number of perforations in a row may depend, inter alia, on the length of the outer balloon 26, the size of the perforations, the physical properties of the material(s) from which the outer balloon 26 is made, the type and chemical-physical characteristics of the drug or therapeutic composition attached to the outer surface 24C of the inner balloon 24 and the particular application of the catheter.
  • the perforation diameter for circular perforations 26F or the perforation area (for non-circular perforations) may (optionally) become larger when the inner balloon 24 is inflated, depending, inter alia, on the degree of compliance of the material from which the outer balloon 26 is made as is disclosed in detail hereinafter.
  • the outer balloon 24 has a proximal end 24A and a distal end 24B.
  • the length of the outer balloon 26 may be larger than the length of the inner balloon 24.
  • the proximal end 26A of the outer balloon 24 is sealingly attached to a third region of the outer surface 22C of the shaft 22 and the distal end 26B of the outer balloon 26 is sealingly attached to a fourth region of the outer surface 22C of the shaft 22.
  • the proximal and distal ends 26 A and 26B, respectively, of the outer balloon 26 may be sealingly attached to the outer surface 22C by gluing or welding or thermal bonding or ultrasonic welding or by any other suitable attachment method as is known in the art.
  • the third region of the surface 22C to which the proximal end 26A of the outer balloon 26 is sealingly attached may be located on the surface 22C proximal to the location of the third region of the surface 22C to which the proximal end 24A of the inner balloon 24 is sealingly attached.
  • the fourth region of the surface 22C to which the distal end 26B of the outer balloon 26 may be sealingly attached may be located on the surface 22C distal to the location of the second region of the surface 22C to which the distal end 24B of the inner balloon 24 is sealingly attached.
  • the length of the outer balloon 26 may be either equal to or shorter than the length of the inner balloon 24.
  • the proximal end of the outer balloon 26 may be sealingly attached directly to the outer surface of the proximal end of the inner balloon 24 and the distal end of the outer balloon 26 may be sealingly attached directly to the outer surface of the distal end of the inner balloon 24. Examples of such balloon attachments are disclosed in detail in Figs. 14-16 hereinafter.
  • the distal ends of the inner balloon and/or the outer balloon of the catheter may be sealingly attached to the soft tip 9 while the proximal end of the inner balloon and/or the outer balloon may be sealingly attached to the surface of the shaft of the catheter.
  • the proximal end of the inner balloon may be sealingly attached to the outer surface of the shaft while the proximal end of the outer balloon is sealingly attached to the outer surface of the proximal end of the inner balloon while the distal end of the inner balloon may be attached to the tip 9 and the distal end of the outer balloon may be sealingly attached to the distal end of the inner balloon.
  • any possible permutations of the attachment of the distal and/or proximal ends of the inner and outer balloons to the surfaces of either the catheter shaft, or the tip 9, or the outer surface of the inner balloon, are possible in implementing some embodiments of the catheters (of both RE and OVT types of catheters) of the present application and are included in the scope of the present invention.
  • Fig. 6 is a schematic transversal cross section illustrating the catheter of Fig. 5 taken along the lines V-V when the inner balloon of the catheter is in a non-inflated state.
  • Fig. 7 is a schematic transversal cross- section taken along the lines V-V of Fig. 5, illustrating the catheter of Fig. 5 when the inner balloon of the catheter is in an inflated state.
  • Fig. 6 the inner balloon 24 is illustrated in a non-inflated state. It is noted that the distance between the outer surface 22C of the shaft 22 and the inner surface 24D of the inner balloon 24 as well as the distance between the outer surface 24C of the inner balloon 24 and the inner surface 26D of the balloon 26 are somewhat exaggerated for the sake of clarity of illustration. In some embodiments of the catheters of the present application, when the inner balloon is in the non-inflated state, some parts or portions of the inner surface 24D of the inner balloon 24 may be in contact with the outer surface 22C of the shaft 22 and some parts or portions of the inner surface 26D of the outer balloon 26 may be in contact with the outer surface 24C of the inner balloon 24.
  • the inner balloon 24 when the inner balloon 24 is inflated with inflation fluid at the nominal inflation pressure, the inner balloon 24 may expand radially to an inflated state. If the inner balloon 24 is made from a compliant material or a semi-compliant material (see detailed definitions and TABLE 1, hereinafter), the cross-sectional area (or the mean diameter) of the inner balloon 24 in the inflated state may be substantially larger than the cross-sectional area (or the mean diameter) of the inner balloon 24 in the non- inflated state as illustrated in Fig. 5.
  • the outer balloon 26 may also expand radially such that the cross-sectional area (or the mean diameter) of the outer balloon 26 after inflation of the inner balloon 24 is larger than the cross-sectional area (or the mean diameter) of the outer balloon 26 before inflation of the inner balloon 24.
  • the parts or portions of the inner balloon 24 which face the perforations 26F may expand and bulge externally out of the perforations 26F to form convex regions which bulge radially and may extend beyond of the perforations 26F as shown in the enlarged detail of Fig. 7 illustrating some regions 24K, 24L and 24M of the inner drug coated balloon 24 which bulge convexly through the opposing open perforations 26F of the outer balloon 26.
  • part of the drug coated external surface of the convex bulging regions may come in contact with the blood vessel wall (not shown in Fig. 7) or with the wall of any other bodily passage within which the catheter 30 is disposed.
  • the contact between the bulging convex regions of the inner balloon 24 may assist the delivery of the drug or active ingredient(s) from the composition coating or attached to the convex bulging regions of the inner balloon 24 to portions of the wall of the treated blood vessel or other body passage being treated.
  • the inner balloon 24 may be made from a compliant material or from a semi-compliant material and the outer balloon 26 may made from a compliant or semi-compliant material. Therefore, after the inner balloon 24 is inflated at the nominal inflation pressure, the area of the perforations 26F may substantially increase relative to the area of the perforations 26F before the inflation of the inner balloon 24 because the outer balloon 26 may substantially radially expand (and elastically stretch) due to the pressure exerted thereon by the expanding inner balloon 24. The elasticity and compliance of the outer balloon 26 may result in a substantial radial expansion (elastic stretching) of the outer balloon 26 in response to the inflation of the inner balloon 24 at the nominal inflation pressure.
  • This elastic stretching and increase in the cross- sectional area of the compliant outer balloon 26 may result in a substantial increase of the area of the perforations 26F of the outer balloon 26 relative to the area of the perforations 26F before the inflation of the inner balloon 4.
  • This substantial increase in the area of the perforations 26F in such a compliant outer balloon enables a larger area of the drug coated outer surface 24C of the inner balloon to protrude and convexly bulge beyond the outer surface 26C of the outer balloon 26 through the enlarged perforations 26F.
  • the perforations 26F may be made to have a relatively small area in the non-inflated (non-expanded) state of the outer balloon 26 in order to advantageously provide improved covering and protection of the drug coated surface 24C of the inner balloon 24 during the insertion and advancing of the catheter 20 through the vasculature (or other bodily passage) to the selected treatment site.
  • the area of the perforations 26F increases, which may substantially increase the total area of the drug coated surface of the inner balloon 24 that contacts the treated region for delivering the drug.
  • catheters having compliant or semi-compliant outer perforated balloons advantageously provide efficient protection of the drug coated outer surface of the inner balloon due to the small area of the perforations in the perforated outer balloon in the non-inflated state of the outer balloon which is the state used for inserting the catheter into the vasculature and moving the distal part of the catheter to the selected region of treatment (such as, for example, an atheroma or plaque or a stenosed part of a blood vessel), resulting in a reduced exposure of the drug coated surface of the inner balloon to the blood, while during treatment by inflation of the inner balloon, such compliant or semi-compliant outer balloons advantageously allow the perforations to substantially increase in area which increases the area of the drug coated external surface of the inner balloon which may protrude through enlarged perforations and contacts the treated region and releasing the drug or active agents released into the treated region or in the vicinity thereof.
  • the selected region of treatment such as, for example, an atheroma or plaque or a stenosed part of a blood vessel
  • the above described effect (of the increase in the area of drug coated surface exposed through the expanded perforations) may be smaller in magnitude than the effect in catheters having a compliant outer balloon and a non-compliant inner balloon but is still significant.
  • the area of drug coated surface exposed through the expanded perforations after inflation of the inner balloon at the nominal pressure increases as the compliance of the outer perforated balloon increases.
  • the first way is to minimize or reduce the size and the cross sectional area of the perforations in the outer perforated balloon during insertion and passage of the catheter through the vasculature.
  • This may be achieved by using compliant or semi-compliant outer perforated balloons having very small perforation diameter or cross sectional area before inflation of the inner balloon, and by producing the perforation in the outer balloon using methods allowing the forming of perforations having a very small cross sectional area (in the non expanded state of the outer balloon).
  • Such methods may include ablative balloon perforation using a laser beam, balloon perforation using hot micro-needles, Photo-etching, die cutting, selective photo-curing or any other method known in the art for producing small perforations in an elastic material.
  • the outer perforated balloon may be made from a very elastic stretchable material (such as, for example, very thin Latex®, Polyurethane, silicone elastomers, PEBAX® 3335, PEBAX® 3325 and ePTFE ( expanded polytetrafluoroethylene).
  • a very elastic stretchable material such as, for example, very thin Latex®, Polyurethane, silicone elastomers, PEBAX® 3335, PEBAX® 3325 and ePTFE ( expanded polytetrafluoroethylene).
  • the outer perforated balloon comprises such very small perforations
  • the exposure of the drug coated outer surface of the inner balloon to the blood during insertion and moving of the catheter within the vasculature is significantly reduced due to the small size and area of the perforations, advantageously reducing drug release into the vasculature prior to reaching the treatment site.
  • the exemplary catheter embodiment illustrated in Figs 1-3 may operate in this way since the area of the perforations 6F in the non-expanded state of the outer balloon 6 illustrated in Fig. 2 is relatively small as compared to the area of the perforations 6F in the expanded state of the outer balloon 6 after inflation of the inner balloon 4 at the nominal inflation pressure, as illustrated in Fig. 3.
  • Such an embodiment may advantageously reduce drug loss during passage of the catheter 10 within the vasculature while allowing significant drug delivery at the treatment site due to substantial increase in the area of the perforations 6F after inflation of the inner balloon 4.
  • the convex bulging of the regions of the drug coated outer surface of the inner balloon 4 may allow contact of the bulging regions with the treated surface of the blood vessel to further improve drug delivery into the target region.
  • a second way to reduce drug washout from the drug coated balloon during passage of the catheter through the vasculature is to fold the drug coated inner balloon such that at least some portions of the outer surface of inner balloon are tightly covered (and thus protected) by other portions of the outer surface of the folded inner balloon.
  • Figs. 8-9 are a schematic transversal cross-sectional views illustrating a drug delivery catheter having a folded inner balloon and a non- folded perforated outer balloon in an non-inflated state and an inflated state, respectively, in accordance with some embodiments of the catheters of the present application.
  • the shaft 2 of the catheter 40 may be configured as an OVT catheter shaft (see Figs. 1-3).
  • the catheter 40 includes the shaft 2, an inner drug coated balloon 44 and an outer perforated balloon 46.
  • the first lumen 2C, the guide wire 3 and the second lumen 2B may be as disclosed in detail with respect to the catheter 10 of Fig. 1.
  • the inner balloon 44 and the perforated outer balloon 46 may be sealingly attached to the shaft 2 as disclosed in detail for the inner balloon 4 and the outer perforated balloon 6 of Fig. 1.
  • any of the methods of sealingly attaching the inner balloons and the outer perforated balloons of the catheters disclosed and/or illustrated in the drawing figures of the present application may be used in implementing the catheter 40.
  • the catheter 40 may or may not include a soft tip (such as, for example, the soft tip 9 of Fig. 1).
  • a soft tip such as, for example, the soft tip 9 of Fig. 1.
  • the distal end of the inner balloon 44 may be sealingly attached to the soft tip
  • the distal end of the outer perforated balloon 46 may be sealingly attached to the soft tip or, alternatively may be sealingly attached to the distal end of the inner balloon 44.
  • the inner balloon 44 may be a non-compliant, or semi-compliant or compliant balloon.
  • the outer perforated balloon 46 may be a compliant balloon or a semi- compliant balloon. In the non-inflated state, the inner balloon 44 may have a diameter larger than the non-radially expanded diameter of the outer perforated balloon 44.
  • the outer surface 44C of the inner balloon 44 is covered with or coated with a drug or composition (not shown in Figs. 8-9 for the sake of clarity of illustration) as disclosed in detail hereinabove with respect to the inner balloon 4 of Fig. 1.
  • the distance between the outer surface 2C of the shaft 2 and the inner surface 44D of the inner balloon 44 as well as the distance between the outer surface 44C of the inner balloon 44 and the inner surface 46D of the outer perforated balloon 46 are somewhat exaggerated in Fig. 8 for the sake of clarity of illustration (in order to clearly discern the different parts and portions of the inner balloon 44 and the outer perforated balloon 46).
  • some parts or portions of the inner surface 44D of the inner balloon 44 may be in contact with the outer surface 2C of the shaft 2 and some parts or portions of the inner surface 46D of the outer perforated balloon 46 may be in contact with the outer surface 44C of the inner balloon 44.
  • the inner balloon 44 when the inner balloon 44 is in the non-inflated state, the inner balloon 44 may be actually folded around the shaft 2 as well as around itself in a much tighter manner than that illustrated in the schematic cross-sectional view of Fig. 8. Such tight folding may advantageously reduce the crossing-profile of the distal part of the catheter 40.
  • the tight folding of the inner balloon 4 around itself also advantageously results in improved protection of at least some portions the drug coated outer surface 44C of the inner balloon 44.
  • the surface region 44K of the outer surface 44C of the inner balloon 44 may be tightly folded over the surface region 44L for protecting the drug coating both surface regions 44K and 44L.
  • the surface region 44M of the outer surface 44C of the inner balloon 44 may be tightly folded over the surface region 44N for protecting the drug coating both surface regions 44M and 44N
  • the surface region 44P of the outer surface 44C of the inner balloon 44 may be tightly folded over the surface region 44Q for protecting the drug coating both surface regions 44P and 44Q.
  • Such tight folding of the inner balloon 44 may prevent any blood entering the outer perforated balloon 46 through the perforations 46F from penetrating between the tightly contacting surface regions 44K and 44L, 44M and 44N, and 44P and 44Q, respectively, or at least substantially reduce the penetration of blood between the contacting surface regions.
  • the amount of blood penetrating between these contacting surface regions is relatively small due to the relatively small area of the perforations 46F of the outer perforated balloon 46 which is in the non-expanded state prior to inflation of the inner balloon 44.
  • the inner surface 46D of the outer perforated balloon 46 may be tightly wrapped around the folded inner balloon 46, such that at least several surface regions of the inner surface 46D may be in tight contact with opposing drug coated outer surface regions of the outer surface 44C of the inner balloon 44.
  • the surface region 46R of the outer perforated balloon 46 may be in tight contact with the opposing surface region 44S of the drug covered outer surface 44C of the inner balloon 44
  • the surface region 46V of the outer perforated balloon 46 may be in tight contact with the opposing surface region 44W of the drug covered outer surface 44C of the inner balloon 44 and so on.
  • This tight contact between such surface regions of the inner surface 46D of the outer perforated balloon 46 and the opposing surface regions of the outer (drug coated) surface 44C of the inner balloon 44, may also protect such opposing regions from premature drug washout by blood in the vasculature and may further improve drug retaining, resulting in higher amounts of the drug being deliverable to the target site after the inner balloon 44 is inflated at the treatment target site.
  • any space available inside the outer perforated balloon 46 may be somewhat fluidically isolated from the main blood flow in the vasculature (mainly due to the relatively small area of the perforations 46F prior to inflation of the inner balloon 44), the mixing of any drug carrying blood held within the outer perforated balloon 46 with the blood flowing within the vasculature may be quite restricted and may possibly even be diffusion limited or close to diffusion limited which advantageously reduces untimely drug elution prior to reaching of the target region and treatment thereof.
  • the double headed arrow Dl schematically represents the diameter of the perforations 46F in the non-expanded state of the outer perforated balloon 46 prior to inflation of the inner balloon 44.
  • the inner balloon 44 expands and unfolds to fill the space within the outer perforated balloon 46 and to push against the inner surface 46D of the outer perforated balloon 46 and expand the diameter of the compliant (or semi-compliant) outer perforated balloon 46.
  • the expansion and elastic stretching of the perforated outer balloon 46 by the inflating inner balloon 44 results in increasing the cross sectional area of the perforations 46F and may allows portions of the drug coated outer surface of the inner balloon 44 to convexly bulge through the enlarged perforations 46F and to eventually come in contact with the treated plaque or atheroma or inner surface of the blood vessel being angioplastically treated by the expanding outer perforated balloon 46 and inner balloon 44.
  • the drug coated convexly bulging regions 44E, 44F, 44G, 44H, 441, and 44J of the outer surface of the inner balloon 46 may come in contact with the surface of the treated region and may deliver the drug thereto.
  • the inflation of the inner balloon 44 performed at the treated region may eject some of the drug containing blood through the enlarged perforations 46F of the expanded perforated outer balloon 46 directly in the vicinity of the treated region, effectively increasing the amount of drug available at the treated region.
  • the double headed arrow D2 schematically represents the diameter of the enlarged perforations 46F after the inner balloon 44 has been inflated at the nominal inflation pressure.
  • the area of the perforations 46F in the non-expanded state of the outer perforated balloon 46 prior to inflation of the inner balloon 44 is SI and the area of the enlarged perforations 46F after the inner balloon 44 has been inflated at the nominal inflation pressure is S2.
  • S2 In embodiments of the catheter 40 having compliant and semi- compliant outer perforated balloons 46, S2>S1.
  • the change in the perforation diameter and area is related to the change in inner balloon diameter.
  • D2/Dl ⁇ d2/dl, and S2/Sl ⁇ (d2/dl)" where dl is the diameter of the inner balloon in the non-inflated state and d2 is the diameter of the inner balloon in the inflated state (which may be the nominal inflated diameter of the inner balloon).
  • the change (increase) in the diameter and/or area of the perforations is related to the inflation pressure within the inner balloon.
  • the change in the area of the perforations is proportional to the of the inflation pressure Pi squared S2/Sloc( Pj) 2 because for non-compliant and semi compliant balloons the balloon diameter is approximately linearly dependent on Pi.
  • compliant, highly elastic balloons such as for example, balloons made of Latex® in which there is no linear dependence of the balloon diameter Pi.
  • the value of the ratio S2/S1 may be somewhat smaller than (d2/dl) as the outer perforated balloon may restrain the radial expansion of the inner balloon.
  • the actual diameter of the inner balloon inflated to the nominal inflation pressure as measured in a catheter including an inner balloon and a perforated outer balloon may be significantly smaller than the diameter of the inner balloon as measured in the inner balloon when the inner balloon is not restricted by an outer perforated balloon (i.e. as measured in a similar catheter having only an inner balloon and lacking the outer perforated balloon).
  • D2i + o is the diameter of the inner balloon inflated to the nominal inflation pressure in a catheter having both an inner balloon and a perforated outer balloon
  • D2i is the diameter of the inner balloon inflated to the nominal inflation pressure in a catheter having only an inner balloon and lacking the outer perforated balloon
  • dli is the diameter of the non inflated inner balloon in a catheter including only an inner balloon
  • dli is the diameter of the inner balloon in a non-inflated state in a catheter including only an inflatable inner balloon
  • This effect may be more prominent in catheters having a compliant inner balloon and a non-compliant or semi compliant outer perforated balloon (due to the higher resistance to expansion of such perforated outer balloons) and may be less prominent in catheters having a compliant inner balloon and a compliant perforated outer balloon.
  • Intermediate effects may occur in catheters having a semi compliant inner balloon and a semi compliant outer perforated balloon.
  • the increase in the diameter and/or the perforation area may depend, inter alia, on the degree of compliance of the inner balloon, the degree of compliance of the outer perforated balloon, the wall thickness of the inner balloon and the outer perforated balloon, and the inflation pressure of the inner balloon.
  • the term Dl refers to the diameter of the outer perforated balloon in an unfolded state and prior to inflation of the inner balloon
  • the term dl refers to the diameter of the inner balloon in an unfolded state and prior to inflation of the inner balloon
  • the term dli refers to the diameter of the inner balloon in an unfolded state and prior to the inflation of the inner balloon.
  • the catheter 40 may be also implemented as a RE catheter by using the shaft 22 as disclosed hereinabove with respect to the catheter 30 of Figs. 5-7 instead of the shaft 2 (as disclosed with respect to Figs 1-3).
  • a RE catheter may be inserted into the vasculature and moved towards a target region over the guide wire 3 as is well known in the art of rapid exchange catheters.
  • the protection of the drug coated inner balloon 44 by the surrounding perforated outer balloon 46, and the inflation of the inner balloon 44 to for treating the target region and for delivering a drug to the treated target region may operate as disclosed in detail hereinabove with respect to Figs. 8-9, irrespective of whether the catheter it is implemented as an OVT catheter or a RE catheter.
  • An additional way to reduce drug washout from the drug coated balloon during passage of the catheter through the vasculature is the folding of both the drug coated inner balloon and the outer perforated balloon of the catheter, such that at least some portions of the outer surface of inner balloon are tightly covered (and thus protected) by other portions of the outer surface of the folded inner balloon and/or to fold the outer perforated balloon over itself, in such a way that at least some of the perforations in the outer perforated balloon are covered or partially covered by folded parts folded of the outer perforated balloon.
  • Figs. 10-11 are a schematic transversal cross- sectional views illustrating a drug delivery catheter having a folded inner balloon and a folded perforated outer balloon, in an non-inflated state and an inflated state, respectively, in accordance with some embodiments of the catheters of the present application.
  • the catheter 50 includes a shaft 2, an inner drug coated balloon 54 attached to the shaft 2 and an outer perforated balloon 56 attached to the shaft 2 and surrounding the inner balloon 54.
  • the shaft 2 of the catheter 50 may be configured as an OVT catheter shaft (see Figs. 1-3).
  • the first lumen 2C of the shaft 2, the guide wire 3 and the second lumen 2B of the shaft 2 may be configured as disclosed in detail with respect to the catheter 10 of Fig. 1.
  • the inner balloon 54 and the perforated outer balloon 56 may be sealingly attached to the shaft 2 as disclosed in detail for the inner balloon 4 and the outer perforated balloon 6 of Fig. 1.
  • any of the methods of sealingly attaching the inner balloons and the outer perforated balloons of the catheters disclosed and/or illustrated in the drawing figures of the present application may be used in implementing the catheter 50.
  • the catheter 50 may or may not include a soft tip (such as, for example, the soft tip 9 of Fig. 1).
  • the distal end of the inner balloon 54 may be sealingly attached to the soft tip
  • the distal end of the outer perforated balloon 56 may be sealingly attached to the soft tip or, alternatively may be sealingly attached to the distal end of the inner balloon 54.
  • the inner balloon 54 may be a non-compliant, or a semi-compliant or a compliant balloon.
  • the outer perforated balloon 56 may be a compliant balloon or a semi- compliant balloon (but may also be a non-compliant balloon in some embodiments of the catheter 50).
  • the outer surface 54C of the inner balloon 54 is covered with or coated with a layer of drug or composition (not shown in Figs. 10-11 for the sake of clarity of illustration) as disclosed in detail hereinabove with respect to the inner balloon 4 of Fig. 1.
  • the perforated outer balloon 56 may have multiple perforations 56F therein.
  • the diameter of the perforations 56F is D3.
  • the cross sectional area of the perforations 56F is S3 (not shown in Fig. 10)
  • the distance between the outer surface 2C of the shaft 2 and the inner surface 54D of the inner balloon 54 as well as the distance between the outer surface 54C of the inner balloon 54 and the inner surface 56D of the outer perforated balloon 56 are somewhat exaggerated in Fig. 10 for the sake of clarity of illustration (in order to clearly discern the different parts and portions of the inner balloon 54 and the outer perforated balloon 56).
  • some parts or portions of the inner surface 54D of the inner balloon 54 may be in contact with the outer surface 2C of the shaft 2 and some parts or portions of the inner surface 56D of the outer perforated balloon 56 may be in close contact with the outer surface 54C of the inner balloon 54.
  • the inner balloon 54 when the inner balloon 54 is in the non-inflated state, the inner balloon 54 may actually be tightly folded around the shaft 2 as well as around certain parts thereof in a much tighter manner than that illustrated in the schematic cross- sectional view of Fig. 10.
  • the outer perforated balloon 56 may be tightly folded around parts of the inner balloon 54 as well as well as around certain parts of itself.
  • Such tight folding arrangement may advantageously reduce the crossing-profile of the distal part of the catheter 50.
  • some or all of the perforations 56F may actually be tightly covered by the corresponding opposing folded regions of the Outer perforated balloon 56.
  • Such an arrangement in which at least some perforations of the plurality of perforations 56F of the perforated outer balloon 56 are disposed within one or more folds of the outer perforated balloon 56 and the folds are tightly folded, may significantly reduce loss of drug during insertion and passage of the catheter into the vasculature or other body cavities.
  • Such a tightly folded arrangement may seal or at least partially seal the perforations 56F and may advantageously reduce or even prevent the penetration of blood (or other bodily fluids) into the perforations 56F which in turn reduces or prevents washout of the drug from the drug coated or drug covered outer surface 54C of the inner balloon 54, resulting in improved drug retention during the insertion of the catheter 50 into the vasculature and the moving of the distal end of the catheter 50 within the vasculature towards the treatment target site.
  • the inner balloon 54 of the catheter 50 when the inner balloon 54 of the catheter 50 is inflated at the nominal inflation pressure, the inner balloon 54 expands and unfolds and causes the outer perforated balloon 56 to also expand and unfold as illustrated in Fig. 11.
  • the perforations 56F may or may not increase in diameter (for perforations having a circular shape) or increase in their area after unfolding and expansion of the outer perforated balloon 56, depending on the properties of the material from which the perforated outer balloon 56 is made. If the perforated outer balloon 56 is non-compliant, there may be a negligible enlargement or no enlargement of the diameter and/or area of the perforations 56F.
  • the perforated outer balloon 56 is semi-compliant or compliant and the perforations 56F are circular, there may be a substantial enlargement of the diameter D4 of the perforations 56F (as illustrated in Fig. 11) such that D4>D3. If the perforated outer balloon 56 is semi-compliant or compliant and the perforations 56F are non-circular, there may be a substantial enlargement of the area S4 of the perforations 56F (as illustrated in Fig. 11) as compared to the area of the perforations S3 when the inner balloon 56, such that S4>S3.
  • the inflation of the inner balloon 54 at the nominal inflation pressure may result in parts of the inflated balloon 54 convexly bulging through the perforations 56F such that portions of drug coated outer surface 54C of the inner balloon 54 may protrude outside of the perforations 56F and may contact the treated region (such as, for example, an atheroma in a blood vessel, a stenosed region of the blood vessel, or a plaque in a blood vessel) and may effectively deliver the drug thereto, as disclosed in detail.
  • the regions 54K, 54L and 54M protrude beyond the outer surface 56C of the expanded outer perforated balloon 56 through the perforations 56F.
  • the catheter 50 may be also implemented as a RE catheter by using the shaft 22 as disclosed hereinabove with respect to the catheter 30 of Figs. 5-7 instead of the shaft 2 (as disclosed with respect to Figs 1-3).
  • a RE catheter may be inserted into the vasculature and moved towards a target region over the guide wire 3 as is well known in the art of rapid exchange catheters.
  • the protection of the drug coated inner balloon 54 by the surrounding perforated outer balloon 56 and the inflation of the inner balloon 54 for treating the target region and for delivering a drug to the treated target region may operate as disclosed in detail hereinabove with respect to Figs.
  • Figs. 12-13 are a schematic transversal cross- sectional views illustrating a drug delivery catheter having a non-folded inner balloon and a folded perforated outer balloon, in an non-inflated state and an inflated state, respectively, in accordance with some embodiments of the catheters of the present application.
  • the catheter 60 includes a shaft 2, an inner drug coated balloon 64 attached to the shaft 2 and an outer perforated balloon 66 attached to the shaft 2 and surrounding the inner balloon 64.
  • the shaft 2 of the catheter 60 may be configured as an OVT catheter shaft (see Figs. 1-3).
  • the first lumen 2C of the shaft 2, the guide wire 3 and the second lumen 2B of the shaft 2 may be configured as disclosed in detail with respect to the catheter 10 of Fig. 1.
  • the inner balloon 64 and the perforated outer balloon 66 may be sealingly attached to the shaft 2 as disclosed in detail for the inner balloon 4 and the outer perforated balloon 6 of Fig. 1.
  • any of the methods of sealingly attaching the inner balloons and the outer perforated balloons of the catheters disclosed and/or illustrated in the drawing figures of the present application may be used in implementing the catheter 60.
  • the catheter 60 may or may not include a soft tip (such as, for example, the soft tip 9 of Fig. 1).
  • the distal end of the inner balloon 64 may be sealingly attached to the soft tip
  • the distal end of the outer perforated balloon 66 may be sealingly attached to the soft tip or, alternatively may be sealingly attached to the distal end of the inner balloon 64.
  • the inner balloon 64 may be a semi-compliant balloon, or a compliant balloon.
  • the outer perforated balloon 66 may be a non-compliant balloon or a semi-compliant balloon (but may also be a compliant balloon in some embodiments of the catheter 50).
  • the outer surface 64C of the inner balloon 64 is covered with or coated with a layer of drug or composition (not shown in Figs. 12-13 for the sake of clarity of illustration) as disclosed in detail hereinabove with respect to the inner balloon 4 of Fig. 1.
  • the Inner balloon 64 may be a non-folded balloon having a cross sectional area (in the non- inflated state) smaller than the cross section area of the outer perforated balloon 66 (in the non-expanded state).
  • the total surface area of the outer perforated balloon 66 in its non-expanded state is larger than the total surface area of the inner balloon 64 in a non- inflated state.
  • the perforated outer balloon 66 may have multiple perforations 66F therein
  • the diameter of the perforations 66F is D5.
  • the area of the perforations 56F is S5 (not shown in Fig. 12).
  • the inner surface 64D of the inner balloon 64 may be in contact with the outer surface 2C of the shaft 2 and some parts or portions of the inner surface 66D of the outer perforated balloon 66 may be in close contact with the outer surface 64C of the inner balloon 64.
  • some portions of the outer perforated balloon 66 may be tightly folded around parts of the inner balloon 64 as well as well as around some other portions of itself. Such tight folding arrangement may advantageously reduce the crossing-profile of the distal part of the catheter 60.
  • the perforations 66F may actually be tightly covered by the corresponding opposing folded regions of the outer perforated balloon 66.
  • the three perforations 66F illustrated in the transversal cross- sectional view of Fig. 12 may be tightly covered by the folded regions 66H, 661 and 66 J opposing the perforations 66F.
  • Such an arrangement in which at least some perforations of the plurality of perforations 66F of the perforated outer balloon 66 are disposed within one or more folds of the outer perforated balloon 66 and the folds are tightly folded, may significantly reduce loss of drug during insertion and passage of the catheter into the vasculature or other body cavities.
  • Such a tightly folded arrangement may seal or at least partially seal the perforations 66F and may advantageously reduce or even prevent the penetration of blood or other bodily fluids into the perforations 66F which in turn reduces or prevents washout of the drug from the drug coated or drug covered outer surface 64C of the inner balloon 64, resulting in improved drug retention during the insertion of the catheter 60 into the vasculature and the moving of the distal end of the catheter 60 within the vasculature towards the treatment target site.
  • the inner balloon 64 of the catheter 60 when the inner balloon 64 of the catheter 60 is inflated at the nominal inflation pressure, the inner balloon 64 expands and its cross sectional area increases and causes the outer perforated balloon 56 to unfold and expand as it is being radially pushed outwardly (away from the shaft 2) by the expanding inflated inner balloon 64, as illustrated in Fig. 13.
  • the perforations 66F may or may not increase in diameter (for perforations having a circular shape) or may or may not increase in their area (for perforations having a non-circular shape) after unfolding and expansion of the outer perforated balloon 66, depending on the properties of the material from which the perforated outer balloon 66 is made. If the perforated outer balloon 66 is non-compliant, there may be a negligible enlargement or no enlargement of the diameter and/or area of the perforations 66F.
  • the perforated outer balloon 66 is a semi-compliant balloon or a compliant balloon and the perforations 66F are circular, there may be a substantial enlargement of the diameter D5 of the perforations 66F (as illustrated in Fig. 13) such that D6>D5. If the perforated outer perforated balloon 66 is a semi-compliant balloon or a compliant balloon and the perforations 66F are non-circular, there may be a substantial enlargement of the area S5 of the perforations 66F, such that S6>S5.
  • the inflation of the inner balloon 64 at the nominal inflation pressure may result in parts of the inflated balloon 64 convexly bulging through the perforations 66F such that portions of drug coated outer surface 64C of the inner balloon 64 may protrude outside of the perforations 66F and may contact the treated region (such as, for example, an atheroma in a blood vessel, a stenosed region of the blood vessel, or a plaque in a blood vessel) and may effectively deliver the drug thereto, as disclosed in detail hereinabove.
  • the regions 64K, 64L and 64M protrude beyond the outer surface 66C of the expanded outer perforated balloon 66 through the perforations 66F.
  • the catheter 60 may be also implemented as a RE catheter by using the shaft 22 (disclosed hereinabove with respect to the catheter 30 of Figs. 5-7) instead of the shaft 2.
  • Such an RE catheter embodiment may be inserted into the vasculature and moved towards a target region over the guide wire 3 as is well known in the art of rapid exchange catheters.
  • the protection of the drug coated inner balloon 64 by the surrounding folded perforated outer balloon 66 and the inflation of the inner balloon 64 for treating the target region and for delivering a drug to the treated target region may be performed as disclosed in detail hereinabove with respect to Figs. 1 and 6-7, irrespective of whether the catheter it is implemented as an OVT catheter or a RE catheter.
  • Figs. 14-16 are a schematic longitudinal cross- sectional views illustrating three different drug delivery catheter parts having three different configurations of attachment of the inner and outer perforated balloons to the catheter, in accordance with some embodiments of the catheters of the present application.
  • the OVT catheter 70 includes the shaft 2 (as disclosed in detail in Fig. 1), an inner drug coated balloon 74 and an outer perforated balloon 76.
  • the inner drug coated balloon 74 may be any type of inner balloon disclosed in the present application and may be made from a non-compliant material or from a semi-compliant material or from a compliant material.
  • the inner balloon 76 may be a folded balloon or a non-folded balloon (prior to inflation thereof) as disclosed hereinabove.
  • the perforated outer balloon 76 has multiple perforations 76F therein.
  • the perforated outer balloon 76 may be any type of outer balloon disclosed in the present application and may be made from a non-compliant material or a semi-compliant material or a compliant material.
  • the outer perforated balloon 76 may be a folded outer balloon or a non-folded outer balloon (prior to the inflation of the inner balloon 74) as disclosed hereinabove.
  • the proximal end 74A of the inner balloon 74 is sealingly attached (by any attachment method disclosed hereinabove) to a first region of the outer surface 2C of the shaft 2 and the distal end 74B of the inner balloon 74 may be sealingly attached to a second region of the outer surface 2C of the shaft 2.
  • the second region of the surface 2C is located distal to the first region of the surface 2C.
  • the proximal end 76A of the outer perforated balloon 76 may be sealingly attached (by any attachment method disclosed hereinabove) to the proximal end 74A of the inner balloon 74.
  • the distal end 76B of the outer perforated balloon 76 may be sealingly attached (by any attachment method disclosed hereinabove) to the distal end 74B of the inner balloon 74.
  • the catheter 70 may be passed over the guide wire 3 that may be disposed in a first lumen 2A of the shaft 2 as disclosed in detail with respect to the catheter 10 of Fig. 1.
  • the inner balloon 74 may be inflated by a suitable inflation fluid (not shown) passing through the opening 2D in the second lumen 2B of the shaft 2 as disclosed in detail with respect to the catheter 10 of Fig. 1.
  • a suitable inflation fluid (not shown) passing through the opening 2D in the second lumen 2B of the shaft 2 as disclosed in detail with respect to the catheter 10 of Fig. 1.
  • the methods of inserting the catheter 70 into the vasculature, moving the catheter 70 towards the target region, inflating the inner balloon 74 for treating the target region and delivering a drug to the target region may be similar to the methods disclosed hereinabove in detail for any of the OVT catheter embodiments disclosed in the present application.
  • the OVT catheter 80 includes the shaft 2 (as disclosed in detail hereinabove and illustrated in Fig. 1), an inner drug coated balloon 84 and an outer perforated balloon 86.
  • the inner drug coated balloon 84 may be any type of inner balloon disclosed in the present application and may be made from a non-compliant material or a semi-compliant material or a compliant material.
  • the inner balloon 86 may be a folded balloon or a non-folded balloon (prior to inflation thereof) as disclosed in detail hereinabove.
  • the perforated outer balloon 86 has multiple perforations 86F therein.
  • the perforated outer balloon 86 may be any type of outer balloon disclosed in the present application and may be made from a non-compliant material or a semi- compliant material or a compliant material.
  • the outer perforated balloon 86 may be a folded outer balloon or a non-folded outer balloon (prior to the inflation of the inner balloon 84) as disclosed hereinabove.
  • the proximal end 84A of the inner balloon 84 is sealingly attached (by any attachment method disclosed hereinabove) to a first region of the outer surface 2C of the shaft 2 and the distal end 84B of the inner balloon 84 may be sealingly attached to a second region of the outer surface 2C of the shaft 2.
  • the second region of the surface 2C is located distal to the first region of the surface 2C.
  • the proximal end 86A of the outer perforated balloon 86 may be sealingly attached (by any attachment method disclosed hereinabove) to a third region of the outer surface 2C of the shaft 2.
  • the third region is located proximal to the first region on the shaft 2.
  • the distal end 86B of the outer perforated balloon 86 may be sealingly attached (by any attachment method disclosed hereinabove) to the distal end 84B of the inner balloon 84.
  • the catheter 80 may be passed over the guide wire 3 that may be disposed in a first lumen 2A of the shaft 2 as disclosed in detail with respect to the catheter 10 of Fig. 1.
  • the inner balloon 84 may be inflated by a suitable inflation fluid (not shown) passing through the opening 2D in the second lumen 2B of the shaft 2, as disclosed in detail with respect to the catheter 10 of Fig. 1.
  • a suitable inflation fluid (not shown) passing through the opening 2D in the second lumen 2B of the shaft 2, as disclosed in detail with respect to the catheter 10 of Fig. 1.
  • the methods of inserting the catheter 80 into the vasculature, moving the catheter 80 towards the target region, inflating the inner balloon 84 for treating the target region and delivering a drug to the target region may be similar to the methods disclosed hereinabove in detail for any of the OVT catheter embodiments disclosed in the present application.
  • the OVT catheter 90 includes the shaft 2 (as disclosed in detail hereinabove and illustrated in Fig. 1), an inner drug coated balloon 94 and an outer perforated balloon 96.
  • the inner drug coated balloon 94 may be any type of inner balloon disclosed in the present application and may be made from a non-compliant material or from a semi-compliant material or from a compliant material.
  • the inner balloon 96 may be a folded balloon or a non-folded balloon (prior to inflation thereof) as disclosed hereinabove.
  • the perforated outer balloon 96 has multiple perforations 96F therein.
  • the perforated outer balloon 96 may be any type of outer balloon disclosed in the present application and may be made from a non-compliant material, or from a semi- compliant material or from a compliant material.
  • the outer perforated balloon 96 may be a folded outer balloon or a non-folded outer balloon (prior to the inflation of the inner balloon 94) as disclosed hereinabove.
  • the proximal end 94A of the inner balloon 94 may be sealingly attached (by any attachment method disclosed hereinabove) to a first region of the outer surface 2C of the shaft 2 and the distal end 94B of the inner balloon 94 may be sealingly attached to a second region of the outer surface 2C of the shaft 2.
  • the second region of the outer surface 2C is located distal to the first region of the surface 2C.
  • the proximal end 96 A of the outer perforated balloon 96 may be sealingly attached (by any attachment method disclosed hereinabove) to the proximal end 94 A of the inner balloon 94.
  • the distal end 96B of the outer perforated balloon 96 may be sealingly attached (by any attachment method disclosed hereinabove) to a third region of the outer surface 2C of the shaft 2 such that the third region of the outer surface 2C is located distal to the second region along the shaft 2 ( as illustrated in Fig. 16).
  • the catheter 90 may be passed over the guide wire 3 that may be disposed in a first lumen 2A of the shaft 2 as disclosed in detail with respect to the catheter 10 of Fig. 1.
  • the inner balloon 94 may be inflated by a suitable inflation fluid (not shown) passing through the opening 2D in the second lumen 2B of the shaft 2 as disclosed in detail with respect to the catheter 10 of Fig. 1.
  • the methods of inserting the catheter 90 into the vasculature, moving the catheter 90 towards the target region, inflating the inner balloon 94 for treating the target region and delivering a drug to the target region may be similar to the methods disclosed hereinabove in detail for any of the OVT catheter embodiments disclosed in the present application.
  • the types of attachment of the inner balloon to the shaft 2 and the methods of attachment of the outer perforated balloon to the shaft 2 or to the proximal end and/or the distal end of the inner balloon are not limited to OVT type of the catheters of the present application and that similar types of attachments may be used in RE catheters in which the shaft construction is similar to that of the shaft 22 of the RE catheter 30 illustrated in Fig. 5.
  • Fig.17 is a schematic side view of part of an assembled drug delivery catheter, in accordance with an embodiment of the catheters of the present application.
  • Fig. 18 is a schematic front view of the catheter of Fig. 17 as viewed in the direction indicated by the arrow F.
  • Fig. 19 is a side view of the outer perforated balloon of the catheter of Fig. 17.
  • Fig. 20 is a schematic side view of the shaft and the inner drug coated balloon of the catheter of Fig. 17.
  • Fig. 21 is a schematic isometric view of the assembled catheter of Fig. 17.
  • the drug delivering catheter 100 includes an RE type double lumen shaft 102 similar in construction and operation of the shaft 22 of the catheter 30 (of Fig. 5).
  • the catheter 100 also includes an inflatable inner drug coated balloon 104 (shown in detail in Fig. 19 hereinafter) and an outer perforated balloon 106. It is noted that the catheter 100 of Figs 17, 18 and 21 is illustrated in a state in which the inner balloon 104 is inflated at the nominal inflated diameter.
  • the inner drug coated balloon 104 may be sealingly attached to the outer surface 102C shaft 102 using any of the attachment methods disclosed in detail hereinabove with respect to the inner balloon 6 of Fig. 1.
  • the inner balloon 104 may be inflated by an inflation fluid introduced into a suitable inflation lumen (not shown) which is formed within the shaft 102.
  • the inflation fluid may enter the inner balloon 106 through a suitable opening in the inflation lumen (not shown in Figs. 17-21).
  • the inflation lumen of the inner balloon 104 may be implemented similar to the lumen 22B of the shaft 22 of Fig. 5 and the opening into the lumen of the inner balloon 104 may be implemented similar to the opening 22D of the shaft 22 of Fig. 5.
  • the inner balloon 104 may be implemented as a non-folded balloon and the outer surface 104C of the inner balloon 104 is coated by or covered with a drug or a drug containing composition as disclosed hereinabove in detail with respect to the inner balloon 4 of Fig. 1.
  • the inner balloon 104 may be made from a compliant material or from a semi-compliant material or from a non-compliant material as disclosed hereinabove.
  • the outer perforated balloon 106 surrounds the inner balloon 104 and may be sealingly attached to the outer surface 102C of the shaft 102.
  • the proximal end 106A and the distal end 106B of outer perforated balloon 106 may be sealingly attached to the shaft 102.
  • any of the attachment configurations of the inner balloons and/or the outer perforated balloons to the shaft 102 and/or to each other disclosed in the present application and illustrated in the drawing figures may be used in various different embodiments of the catheter 100, such as, for example, the attachment configurations illustrated in Figs 1, 14, 15 and 16.
  • the catheter 100 of Fig. 21 does not include a soft tip
  • at least some embodiments of the catheter 100 may also include a soft tip similar to the soft tip 9 of Fig. 1.
  • the distal end of the inner balloon 104 and/or the distal end of outer perforated balloon 106 or both distal ends of the inner balloon 104 and the outer perforated balloon 106 may be attached to the soft tip 9.
  • the distal end of the inner balloon 104 may be sealingly attached to the soft tip 9 and the distal end 106B of the outer perforated balloon 106 may be sealingly attached to the distal end of the inner balloon 104.
  • the outer perforated balloon 106 has multiple circular perforations 106F therein.
  • the perforations 106F are arranged on the outer perforated balloon 106 in four linear rows, each row includes twelve perforations 106F.
  • this is not obligatory to practicing the invention and any practical number of rows may be used, with each row including any practical number of perforations depending, inter alia, on the perforation size and shape, the diameter of the outer perforated balloon, the length of the balloon and other considerations.
  • the perforations may also be arranged, if desired, in any practically desired arrangement, including but not limited to, non-linear rows, helical rows, multiple helical rows or even in a random or other non-random but non-uniform arrangement as is disclosed hereinabove in detail for other catheter embodiments.
  • the diameter of the circular perforations 106F is relatively large after the inner balloon has been inflated
  • the diameter of the perforations 106F may be either quite small (as compared to the diameter of the same perforations 106F in the state before the inner balloon 104 has been inflated).
  • the outer perforated balloon 106 may be made from a compliant material or from a semi-compliant material and may be able to elastically expand when pushed out by the inner balloon 104 during and after inflation of the inner balloon 104, resulting in a substantial increase in the diameter of the perforations 106F due to the elastic expansion of the outer perforated balloon 106 due to inflation of the inner balloon 104.
  • the outer perforated balloon 106 may be made from a non-compliant material, in which case the diameter of the perforations 106F may not significantly change or may increase very little during and after the inflation of the inner balloon 104.
  • the inner balloon 104 of Fig. 20 is illustrated in an inflated state for the sake of clarity of illustration and the outer perforated balloon 106 of Fig. 19 is illustrated in a fully expanded state (as it would be after the inner balloon has been inflated to the nominal inflated diameter), in at least some embodiments of the catheter 100 in the state preceding the inflation of the inner balloon 104, either the inner balloon 104 or the outer perforated balloon 106 or both the inner balloon 104 and the outer perforated balloon 106 may be folded around the shaft 102 and/or around the inner balloon 104 as disclosed in detail with respect to the catheters 40, 50 and 60 ( of Figs. 8, 10 and 12, respectively).
  • the inner balloon 104 and/or the outer perforated balloon 106 may be in a non-folded configuration as disclosed in detail hereinabove with respect to the catheter 10 of Fig. 2.
  • any such combination and permutation of configurations the outer perforated balloon 106 and the inner balloon 104 in the state before inflation of the inner balloon 104 is possible in different embodiments of the catheter 100.
  • Such combinations may include for example, the inner balloon 104 being non-folded and the perforated outer ballool06 being non-folded, the inner balloon 104 being non-folded and the perforated outer balloon 106 being folded, the inner balloon 104 being folded and the perforated outer balloon 106 being non-folded, and both the inner balloon 104 and the perforated outer balloon 106 being folded.
  • the pressure inside the inflated inner balloon 104 causes the multiple regions 104P of the inner balloon 104 facing the perforations 106F to further expand and convexly bulge through the perforations 106 and protrude radially beyond the outer surface 106C.
  • the outer surface of the regions 106P is coated or covered by a drug or a composition as disclosed in detail hereinabove, after the inflation of the inner balloon 104 at the treatment site, the drug may be delivered to the treatment site at the regions of contact between the drug coated surfaces of the regions 104P and the treated region.
  • the protective effects of the outer perforated balloon 106 of the catheter 100 resulting in reducing drug loss during passage within the vasculature may operate, in accordance with the particular configurations of the embodiments of the catheter 100, as disclosed in detail hereinabove with respect to any of the catheters 10, 20, 30, 40, 50, 60, 70, 80 and 90.
  • the type of catheter shaft usable in the drug delivery catheters of the present application is not limited to the shaft types disclosed hereinabove.
  • the catheter shafts of the drug delivery catheters of the present application may have three lumens where a first lumen (not shown) is used for inflation of the inflatable inner balloon, a second lumen for passing a guide wire there through and a third lumen (not shown) that may be used f or injecting a contrast enhancing fluid there through or for inserting a medical instrument there through (either a diagnostic medical instrument such as, for example an IVUS diagnostic catheter or probe, or any other type of medical diagnostic device) or a medical device for treating the treatment site (such as, for example, a surgical microblade, a rotablator device, a laser fiber for tissue ab
  • triple lumen shafts may therefore be used in some embodiments of the drug delivery catheters of the present application.
  • some embodiments of the catheters of the present application may include a number of lumens which may be greater than three lumens (i.e. catheter shafts including 4 or 5 lumens may be implemented in the drug delivery catheters disclosed herein, if needed, depending, inter alia, on the specific application, the allowable diameter of the catheter shaft, the type of required treatment and other considerations.
  • the catheter shaft may include two conduits as disclosed hereinafter.
  • FIG. 22 is a schematic longitudinal cross sectional view illustrating a rapid exchange (RE) drug delivery catheter having a catheter shaft including an outer conduit and an inner conduit, in accordance with an embodiment of the drug delivery catheters of the present application.
  • RE rapid exchange
  • the rapid exchange drug delivery catheter 20 includes a catheter shaft 202 that includes an outer conduit 207 and an angled inner conduit 205 disposed within the outer conduit 207.
  • the catheter 200 also includes an inflatable drug coated inner balloon 204 attached to the distal portion of the shaft 202, an outer perforated balloon 206 attached to the distal portion of the shaft 202 and a hollow connector member 212 sealingly attached to the proximal portion of the shaft 202.
  • the proximal part of the connector member 212 includes a fluid port 212A having a hollow passage 216 passing there through.
  • the inner conduit 207 has an outer diameter that is smaller than the diameter of the lumen 220 of the outer conduit 207.
  • the proximal end 207P of the outer conduit 207 is firmly and sealingly attached to a recess 212R formed in the distal portion of the connector member 212, by suitably bonding or gluing or welding or ultrasonically welding of the proximal part 207P within the recess 212R.
  • the drug coated inner inflatable balloon 204 has a proximal end 204A sealingly attached to the outer surface of the distal end 207D of the outer conduit 207 by bonding or gluing or thermal bonding or ultrasonic welding, using any of the attaching or bonding or gluing or welding methods described in detail hereinabove.
  • the balloon 204 has a distal end 204B sealingly attached to the outer surface 205C of the distal end 205D of the inner conduit 205 by bonding or gluing or welding or ultrasonic welding, using any of the attaching or bonding or gluing or welding methods described in detail hereinabove.
  • the balloon 204 is fluidically in communication with the fluid port 212A through the lumen 220 of the outer conduit 207.
  • Inflation fluid (not shown) may be introduced into the lumen 220 and therefrom into the lumen of the inner balloon 204 through the passage 216 formed in a fluid port 212A, as disclosed in detail hereinabove by using an indeflator (not Shown) or a syringe (not shown) filled with inflation fluid connected to the fluid port 212A.
  • the inner conduit 205 has a straight portion 205B and an angled portion 205A which is bent or inclined at an angle to the straight portion 205B.
  • the angled portion 205 A pierces the wall of the outer conduit 207 and is sealingly and firmly attached to the wall of the outer conduit 207 to prevent leakage of any inflation fluid introduced into the lumen 220 through the opening 216 of the fluid port 212A.
  • the inner conduit 205 is longitudinally fixed relative to the outer conduit 207 and is longitudinally unmovable relative to the outer conduit 207 (i.e., the inner conduit 205 cannot be moved in the proximal or distal direction relative to the outer conduit 207).
  • the distal end 205D of the inner conduit 205 extends distally beyond the distal end 207D of the outer conduit 207 such that a portion of the inner conduit 205 protrudes distally and extends distally beyond the distal end 207D of the outer conduit 207.
  • a hollow soft tip 209 may (optionally, but not obligatorily) be attached to the distal end 205D of the inner conduit 205 (as disclosed in detail with respect to the soft tip 9 of Fig. 1).
  • An opening 215 is disposed in the wall of the outer conduit 207 at the proximal end of the angled portion 205 A of the inner conduit 205.
  • the opening 215 allows the insertion of a guide wire 3 into the lumen 213 of the inner conduit 205.
  • the guide wire 3 may be pushed through the lumen 213 until it exits from an opening 209A at the distal end of the soft tip 209.
  • the perforated outer balloon 206 has a distal end 206B and a proximal end 206A.
  • the proximal end 206A of the balloon 206 is sealingly attached to the distal end 207D of the outer conduit 207 by gluing, bonding, thermal bonding, ultrasonic welding or by any other suitable attachment method.
  • the distal end 206B of the outer perforated balloon 206 is sealingly attached to the distal end 205D of the inner conduit 205 by gluing, bonding, thermal bonding, ultrasonic welding or by any other suitable attachment method.
  • the inflatable inner balloon 204 and the perforated outer balloon 206 may be arranged around the catheter shaft 202 in a non-wrapped (non- folded) arrangement similar to the arrangement of the balloons 4 and 6 around the shaft 2 as illustrated in Figs. 2-3 hereinabove.
  • the inner balloon 205 surrounds is not folded and surrounds the distal portion of the inner conduit 205 that protrudes distally beyond the distal end 207D of the outer conduit 207, and the outer perforated balloon 207 is also not folded and surrounds the inner balloon 204.
  • the inflatable inner balloon 204 and the perforated outer balloon 206 may be arranged around the catheter shaft 202 in a wrapped (folded) arrangement similar to the arrangement of the balloons 44 and 46 around the shaft 2 as illustrated in Figs 8-9 hereinabove.
  • the inner balloon 204 is wrapped or folded around the distal portion of the inner conduit 205 that protrudes distally beyond the distal end 207D of the outer conduit 207 and the outer perforated balloon 206 is not folded and surrounds the folded inner balloon 204.
  • the inflatable inner balloon 204 and the perforated outer balloon 206 may be arranged around the catheter shaft 202 in a wrapped (folded) arrangement similar to the arrangement of the balloons 54 and 56 around the catheter shaft 2 as illustrated in Figs 10-11 hereinabove.
  • the inner balloon 204 is wrapped or folded around the distal portion of the inner conduit 205 that protrudes distally beyond the distal end 207D of the outer conduit 207 and the outer perforated balloon 206 is wrapped or folded around the inner balloon 204
  • the inflatable inner balloon 204 and the perforated outer balloon 206 may be arranged around the catheter shaft 202 such that the inner balloon 204 surrounds the inner conduit 205 in a non-folded arrangement and the outer perforated balloon 206 is arranged in wrapped (folded) arrangement around the distal part 207D of the outer conduit 207 and around the non-folded inner balloon 205 that surrounds the distal part 205D of the inner conduit 205.
  • This arrangement is similar to the arrangement of the balloons 64 and 66 around the catheter shaft 2 as illustrated in Figs 12-13 hereinabove.
  • the various steps of operating the rapid exchange catheter 200 are similar to the steps of operating the over the wire (OVT) catheters and the rapid exchange (RE) as described hereinabove and illustrated in Figs. 1-21, with the exception that the guide wire 3 is inserted into the lumen 213 of the inner conduit 205 through the opening 215 disposed on the wall of the outer conduit 207
  • other steps of the operation of the catheter 200 including inserting the catheter into the body or bodily vasculature, moving the catheter within the vasculature to reach a region to be treated, inflating the inner balloon 204 to expand the inner balloon 204 and the outer balloon 206 for treating a constriction or atheromatous plaque within the vessel (as illustrated in Figs.
  • the lower crossing profile achieved by the folded configuration improves the passability and pushability of the distal end of the catheter 200, into and/or through the blood vessel and/or a constricted region such as an atheroma or plaque in an atheromatous blood vessel.
  • FIG. 23 is a schematic longitudinal cross sectional view illustrating an "over the wire” (OVT) drug delivery catheter having a catheter shaft including an outer conduit and an inner conduit, in accordance with an embodiment of the drug delivery catheters of the present application.
  • OPT over the wire
  • the OVT catheter 300 includes a catheter shaft 302, an inner drug coated inflatable balloon 304, an outer perforated balloon 306 and a connector member 312.
  • the shaft 302 includes an outer conduit 307 and an inner conduit 305 disposed within the outer conduit 307.
  • the inner inflatable balloon 304 is similar in structure and composition to the inner inflatable balloon.
  • the outer conduit 307 is preferably (but not obligatorily) a tubular conduit.
  • the outer conduit 307 has a distal end 307D and a proximal end 307P.
  • the inner conduit 305 is disposed within the lumen 320 of the outer conduit 307.
  • the inner conduit 305 is also preferably (but not obligatorily) a tubular conduit having an outer diameter smaller than the diameter of the lumen 320 of the outer conduit 307.
  • the inner conduit 305 has a distal end 305D and a proximal end 305P.
  • the distal end 305D of the inner conduit 305 extends (protrudes) beyond the distal end 307D of the outer conduit 307 such that a distal portion of the inner conduit 305 protrudes distally from and extends distally beyond the distal end 307D of the outer conduit 307.
  • the inner conduit 305 and the outer conduit 307 may be made from flexible materials, such as but not limited to, Nylon ® , Pebax ® , polyurethane, Polyethyleneterephtalate (PET), stainless steel or from any other suitable flexible material as disclosed in detail hereinabove with respect to the shaft 2 (of Fig. 1).
  • flexible materials such as but not limited to, Nylon ® , Pebax ® , polyurethane, Polyethyleneterephtalate (PET), stainless steel or from any other suitable flexible material as disclosed in detail hereinabove with respect to the shaft 2 (of Fig. 1).
  • the proximal end 305P of the inner conduit 305 and the proximal end 307P of the outer conduit 307 are sealingly and firmly attached to the connector member 312 as illustrated in Fig. 23.
  • the attachment of the proximal ends 305P and 307P to the connector member 312 may be done by bonding, thermal bonding, gluing or by any other suitable attaching method.
  • the connector member 312 may be made from any suitable material, including but not limited to, a polymer, a metal or an alloy (such as, but not limited to, PEBAX, Stainless steel or any other suitable engineering plastic or polymer based structural material). Due to the firm attachment of the proximal ends 305P and 307P to the connector member 312, the inner conduit 305 is not movable longitudinally with respect to the outer conduit 307.
  • the connector member 312 has two hollow passages therein.
  • a first hollow passage 316 opens into the lumen of the inner conduit 6 and allows the insertion of a guide wire 14 into and through the lumen of the inner conduit 313 through a guide wire insertion port 312A of the connector member 312.
  • the lumen 313 may be passed over a guide wire 3, and the guide wire 3 may be used to guide the insertion of the catheter 300 into a treatment region within a body passage (such as, but not limited to, a blood vessel).
  • a second hollow passage 318 is formed within a fluid port 312B of the connector member 312 that allows the introduction of an inflation fluid into the space 320 formed between the inner surface 307C of the outer conduit 307 and the outer surface 305C of the inner conduit 305. If the inner conduit 305 and the outer conduit 307 have a circular cross-section, the lumen 320 is an annular lumen.
  • the inner conduit 305 is axially unmovable and cannot be longitudinally moved with respect to the outer conduit 307 in the proximal- distal direction.
  • the shaft 302 of the catheter 300 may be flexed and bent sideways such that it is capable of being pushed along the guide wire 3 within tortuous or bending bodily passages (such as, but not limited to, blood vessels).
  • the inflatable inner balloon 304 and the perforated outer balloon 306 may be similar in construction and composition to the inflatable inner balloon 4 and the perforated outer balloon 6, respectively (of Figs. 1-3), as disclosed in detail hereinabove.
  • the inner balloon 304 is typically capable of withstanding inflation pressures within the range of 4-25 atmospheres. However, the inner balloon 304 may be implemented to withstand inflation pressures lower than 4 atmospheres or higher than 25 atmospheres, depending, inter alia on the balloon dimensions, balloon wall thickness, the material from which the balloon is made and the specific application for which the catheter is designed.
  • Typical dimensions of the inner balloon 304 may be a balloon diameter in the range of 2-8 millimeters, a balloon length in the range of 8-300 millimeters and a balloon wall thickness in the range of 0.01- 0.1 millimeters.
  • these ranges are by no means obligatory or limiting and other higher or lower values of the balloon length, balloon diameter and balloon wall thickness which are outside the typical ranges indicated above may also be used, depending, inter alia, on the specific application for which the catheter is designed.
  • the inflatable inner balloon 304 and the perforated outer balloon 306 may be arranged around the catheter shaft 302 in a non-wrapped (non- folded) arrangement similar to the arrangement of the balloons 4 and 6 around the shaft 2 as illustrated in Figs. 2-3 hereinabove.
  • the inner balloon 305 surrounds is not folded and surrounds the distal portion of the inner conduit 305 that protrudes distally beyond the distal end 307D of the outer conduit 307, and the outer perforated balloon 307 is also not folded and surrounds the inner balloon 304.
  • the inflatable inner balloon 304 and the perforated outer balloon 306 may be arranged around the catheter shaft 302 in a wrapped (folded) arrangement similar to the arrangement of the balloons 44 and 46 around the shaft 2 as illustrated in Figs 8-9 hereinabove.
  • the inner balloon 304 is wrapped or folded around the distal portion of the inner conduit 305 that protrudes distally beyond the distal end 307D of the outer conduit 307, and the outer perforated balloon 306 is not folded and surrounds the folded inner balloon 304.
  • the inflatable inner balloon 304 and the perforated outer balloon 306 may be arranged around the catheter shaft 302 in a wrapped (folded) arrangement similar to the arrangement of the balloons 54 and 56 around the catheter shaft 2 as illustrated in Figs 10-11 hereinabove.
  • the inner balloon 304 is wrapped or folded around the distal portion of the inner conduit 305 that protrudes distally beyond the distal end 307D of the outer conduit 307 and the outer perforated balloon 306 is wrapped or folded around the inner balloon 304.
  • the inflatable inner balloon 304 and the perforated outer balloon 306 may be arranged around the catheter shaft 302 such that the inner balloon 304 surrounds the inner conduit 305 in a non-folded arrangement and the outer perforated balloon 306 is arranged in wrapped (folded) arrangement around the distal part 307D of the outer conduit 307 and around the non-folded inner balloon 305 that surrounds the distal part 305D of the inner conduit 305.
  • This arrangement is similar to the arrangement of the balloons 64 and 66 around the catheter shaft 2 as illustrated in Figs 12-13 hereinabove.
  • the various steps of operating the OVT catheter 300 are similar to the steps of operating the over the wire (OVT) catheters and the rapid exchange (RE) as described hereinabove and illustrated in Figs. 1-22, with the exception that the guide wire 3 is inserted into the lumen 313 of the inner conduit 305 through the opening of the hollow passage 516 of the guide wire insertion port 312A
  • other steps of the operation of the catheter 300 may be similar to the steps disclosed hereinabove with respect to the operation of any of the catheters disclosed herein, including inserting the catheter 300 into the body or bodily vasculature, moving the catheter 300 within the vasculature to reach a region to be treated, inflating the inner balloon 304 to expand (and/or unfold, where relevant, depending on the specific arrangement of the inner balloon 304 and the outer perforated balloon of the catheter embodiment being used) the inner balloon 304 and the outer balloon 306 for treating a constriction or atheromatous plaque within the vessel (as illustrated in Figs.
  • the lower crossing profile achieved by the folded configuration improves the passability and pushability of the distal end of the catheter 300, into and/or through the blood vessel and/or a constricted vessel region such as an atheroma or plaque in an atheromatous blood vessel.
  • the shapes of the inflatable drug coated inner balloons and of the perforated outer balloons of the drug delivery catheters of the present application are not limited to the balloon shapes disclosed hereinabove and illustrated in Figs. 1-23. Rather the inflatable inner balloons and the perforated outer balloons of the drug delivery catheters of the present application may have any suitable shape depending, inter alia on the application.
  • Fig. 24 is a schematic cross sectional view illustrating part of an OVT drug delivery balloon catheter, having a conically shaped inflatable inner balloon and a conically shaped perforated outer balloon, in accordance with an embodiment of the catheters of the present application.
  • the catheter 400 (only part of which is illustrated in Fig. 24) may configured as an "over the wire” (OVT) catheter.
  • the catheter 400 may include a hollow shaft 2, a conically shaped inflatable inner balloon 404 attached to the shaft 2 and a perforated conically shaped outer balloon 406 attached to the shaft 2.
  • the balloons 404 and 406 may be made from any of the materials disclosed hereinabove.
  • the outer surface 404C of the inflatable inner balloon 404 is coated with a drug or with a composition comprising a drug (or a combination of drugs) as disclosed in detail hereinabove with respect to the balloon 4 of Fig. 1.
  • proximal end 404A and distal end 404B of the balloon 404 and of the proximal end 406A and the distal end 406B of the balloon 406 to various regions of the surface 2C of the shaft 2 may be used in different embodiments of the catheter 400.
  • the inner balloon 404 may be non-folded. In some other embodiments, the balloon 404 may be folded around the shaft 2. In some embodiments, the perforated outer balloon 406 may be non-folded. In some other embodiments, the perforated outer balloon 406 may be folded around the inner balloon 404 and/or portion(s) of the shaft 2. The arrangement of such different combinations and permutations of folding arrangements may be similar to the arrangements illustrated in Figs. 2,3,5,6, and 8-11).
  • the conical inner balloon 404 When the conical inner balloon 404 is inflated, it may unfold (if it was folded initially) and expand to reach a nominal inflated diameter. The inflation and expansion of the balloon 404 may result in unfolding the perforated outer balloon 406 ( if it was folded initially) and expands the outer perforated balloon 406. If the inner balloon 404 and/or the perforated balloon 406 are made from a stretchable material, the balloons 404 and/or 406 may also stretch following the inflation of the inflatable balloon 404.
  • the diameter and/or the area of the perforations 406F may increase compared to their diameter and area prior to inflation of the inner inflatable balloon 404.
  • This perforation enlarging action may increase the area of the portions of drug coated outer surface 404C of the inner balloon 404 which may protrude through the perforations 406F to contact the treated region (of the body cavity or blood vessel), which may result in more efficient drug transfer to the treated region, as disclosed in detail hereinabove for other embodiments of the catheters.
  • the shaft 2 may be similar to the shaft 2 of Fig. 1 as disclosed in detail hereinabove and is a double lumen hollow shaft having a first lumen 2A for passing the catheter 400 over a guide wire 3, and a second lumen 2B for passing inflation fluid there through for inflating the inflatable inner balloon 404 through an opening 2D.
  • a proximal connector member (not shown in Fig. 24) of the catheter 400 may be similar to the connector member 15 of Fig. 1 hereinabove.
  • the proximal connector member 15 may be used for inflating and/or deflating the inflatable inner balloon 404 through the inflation port 15B as disclosed in detail hereinabove for the catheter 10 of Fig. 1.
  • the passing of the catheter 400 over a guide wire 3 may be performed using the opening 9B of the soft tip 9 and the guide wire insertion port 15A of the proximal connector member 15, as disclosed in detail hereinabove with respect to the catheter 10 of Fig. 1.
  • the proximal end 404A of the inner balloon 404 is sealingly attached to a first region of the outer surface 2C of the shaft 2 and the distal end 404B of the inner balloon 404 is sealingly attached to a second region of the outer surface 2C of the shaft 2.
  • the proximal and distal end 404A and 404B, respectively, of the inner balloon 404 may be sealingly attached to the outer surface 2C by gluing or welding or thermal bonding or ultrasonic welding or by any other suitable attachment method.
  • the outer surface 4C of the inner balloon 4 is coated or covered with a layer of a drug or a layer of a material composition or therapeutic formulation or therapeutic composition comprising one or more drugs and/or active agents, and/or active ingredient(s) as is disclosed in detail for the balloon 4 hereinabove (it is noted that, in all of the drawing figures the catheter embodiments disclosed in the present application, the layer of drug or composition coating the outer surface of the inner balloons is not shown, for the sake of clarity of illustration).
  • the inflatable inner balloon 404 and the perforated outer balloon 406 are generally conically shaped balloons which may have tapering ends.
  • Such conical balloons may be effectively used in cases in which the part of the vasculature that needs to be treated is also conically shaped.
  • such conical balloons may be used for treating lesions and/or opening constricted regions of peripheral blood vessels such as, for example, peripheral veins of the legs or the arms or in any other type of blood vessel or bodily cavity that has a conical shape.
  • the distance between the outer surface 2C of the shaft 2 and the inner surface 404D of the inner balloon 404 as well as the distance between the outer surface 404C of the inner balloon 404 and the inner surface 406D of the balloon 406 are somewhat exaggerated in Fig. 24 for the sake of clarity of illustration (in order to clearly discern the different parts and portions of the inner balloon 404, the outer balloon 506 and the shaft 2).
  • some parts or portions of the inner surface 404D of the inner balloon 404 may be in contact with the outer surface 2C of the shaft 2 and some parts or portions of the inner surface 406D of the outer balloon 406 may be in contact with the outer surface 404C of the inner balloon 404.
  • FIG. 25 is a schematic cross sectional view illustrating part of an OVT drug delivery balloon catheter having stepped inner and outer balloons illustrated in an inflated state, in accordance with an embodiment of the catheters of the present application.
  • the catheter 500 (only a part of which is illustrated in Fig. 25) may include the catheter shaft 2 as disclosed in detail hereinabove a stepped inflatable drug coated inner balloon 504 sealingly attached to the shaft 2, a stepped perforated outer balloon 506 that may be sealingly attached to the shaft 2 and the hollow soft tip 9 attached to the distal end of the shaft 2 as disclosed in detail hereinabove.
  • the proximal end 504 A of the inner balloon 504 is sealingly attached to the outer surface 2C of the shaft 2.
  • the distal end 504B of the inner balloon 504 is sealingly attached to the outer surface 2C of the shaft 2.
  • the proximal end 506A of the inner balloon 504 is sealingly attached to the outer surface 2C of the shaft 2.
  • the distal end 506B of the inner balloon 506 is sealingly attached to the outer surface 2C of the shaft 2.
  • the inflation and expansion of the inner balloon 504 of may result in the opening (and/or unfolding, if the outer balloon 506 is in a folded state prior to inflation of the inner balloon 504) and expanding of the outer perforated balloon 506.
  • the expansion of the outer perforated balloon 506 may result in an in the open area of the multiple perforations 506F of the outer balloon 506, as disclosed hereinabove in detail with respect to other catheter embodiments.
  • the parts or portions of the balloon 504 underlying the perforations 506F may bulge or become convexly curved and/or may protrude beyond the outer surface of the perforated balloon 506.
  • the exemplary convexly curved protruding portions 504K, 504L and 504M of the inner balloon 504 protrude out of the corresponding perforations 506F and their drug or composition coated outer surfaces may come in contact with the region to be treated( not shown in Fig. 25), as disclosed in detail hereinabove with respect to the catheters 10, 20, 30, 40 and 50.
  • the stepped perforated outer balloon 506 When the inner balloon 504 is inflated to the nominal inflation pressure (as illustrated in Fig. 25), the stepped perforated outer balloon 506 has a substantially cylindrical proximal portion (schematically underlying the double headed arrow U), a substantially cylindrical middle portion (schematically underlying the double headed arrow V), and a distal portion (schematically underlying the double headed arrow W).
  • the inner balloon 504 When the inner balloon 504 is inflated to the nominal inflation pressure, the inner balloon 504 has a substantially cylindrical proximal portion (schematically underlying the double headed arrow U), a substantially cylindrical middle portion (schematically underlying the double headed arrow V), and a distal portion (schematically underlying the double headed arrow W).
  • the diameter of the cylindrical middle portion of the balloon 504 is larger than the diameter of the proximal and distal cylindrical portions of the inner balloon 504.
  • the diameter of the cylindrical middle portion of the outer balloon 506 is larger than the diameter of the proximal and distal cylindrical portions of the outer balloon 506.
  • the entire outer surface 504C of the inner balloon 504 may be coated or covered by the drug(s) or the composition comprising a drug (or drugs). In some other embodiments, only a portion or part of the outer surface 504C of the inner balloon 504 may be coated with such drug(s) or composition including a drug (or drugs). For example, in the embodiment illustrated in Fig. 25, only the portion of the outer surface 504C of the middle portion of the inner balloon 504 may coated with the drug(s) or composition.
  • each of the inner stepped inflatable balloon 504 and/or the outer perforated balloon 506 may be either folded or non-folded, and all possible combinations of folded and non-folded balloons disclosed in the present application for other catheter embodiments may be applied to the arrangement of the balloons 504 and 506 of the catheter 500 in different embodiments thereof.
  • the inner balloon 504 in the non-inflated or pre-inflated state of the catheter 500, in some embodiments, the inner balloon 504 may be non-folded and the outer balloon 506 may be non-folded. In other embodiments, the inner balloon 504 may be non-folded and the outer balloon 506 may be folded. In yet other embodiments, the inner balloon 504 may be folded and the outer balloon 506 may be non-folded. In other embodiments, the inner balloon 504 may be folded and the outer balloon 506 may be folded.
  • the attachment of the proximal ends (504A and 506A) and the distal ends (504B and 506B) of the inner balloon 504 and the outer balloon 506, respectively, to various different regions of the outer surface 2C of the shaft 2 and/or to each other, may be arranged, in different embodiments of the catheter with stepped balloons, in any of the types of attachment arrangements disclosed in detail hereinabove with respect to the catheters 10, 20, 30, 40, 50, 70, 80 and 90.
  • the inner inflatable balloons disclosed in the present application may be a non-compliant or semi-compliant balloon which may be made from a suitable polymer based material, such as, but not limited to, Nylon ® (such as, for example, Nylon 12 ® ), PET, polyamide (PA) such as PA12 (for example Grilamid ® L25, L55 and the like), PA11, Polyether block amides (PEBA, such as for example PEBAX ® 7233, PEBAX ® 7033 and PEBAX ® 6333), various types of Grilflex ® (such as, for example, ELG 6260), and the like.
  • a suitable polymer based material such as, but not limited to, Nylon ® (such as, for example, Nylon 12 ® ), PET, polyamide (PA) such as PA12 (for example Grilamid ® L25, L55 and the like), PA11, Polyether block amides (PEBA, such as for example PEBAX ® 7233, PEBAX ® 70
  • the inflatable inner balloons used may be made of a highly compliant material such as, for example, rubber, Latex® and any other highly compliant biocompatible elastic materials known in the art.
  • a highly compliant material such as, for example, rubber, Latex® and any other highly compliant biocompatible elastic materials known in the art.
  • any other suitable biocompatible material known in the art and suitable for fabrication of catheter balloons may be used in implementing the balloons of the present application.
  • the outer perforated balloons disclosed in the present application may be a non- compliant balloon or a semi-compliant balloon which may be made from a suitable polymer based material, such as, but not limited to, Nylon ® (such as, for example Nylon 12 ® ), PET, polyamide (PA) such as PA12 (for example Grilamid ® L25, L55 and the like), PA11, Polyether block amides (PEBA, such as for example PEBAX ® 7233, PEBAX ® 7033 and PEBAX ® 6333), various types of Grilflex ® (such as, for example, ELG 6260), or any other suitably biocompatible compliant or semi-compliant material known in the art.
  • a suitable polymer based material such as, but not limited to, Nylon ® (such as, for example Nylon 12 ® ), PET, polyamide (PA) such as PA12 (for example Grilamid ® L25, L55 and the like), PA11, Polyether block amides (PEBA
  • the outer perforated balloons used in some of the catheters of the present application may be made of a highly compliant material such as, for example, rubber, Latex® and any other highly compliant biocompatible elastic materials known in the art.
  • a highly compliant material such as, for example, rubber, Latex® and any other highly compliant biocompatible elastic materials known in the art.
  • any other suitable biocompatible material known in the art and suitable for fabrication of catheter balloons may be used in implementing the balloons of the present application.
  • Typical dimensions of the perforated outer balloons may be a balloon diameter in the range of 2-8 millimeters, a balloon length in the range of 8-300 millimeters and a balloon wall thickness in the range of 0.01-0.1 millimeters.
  • these ranges are by no means obligatory or limiting and other higher or lower values of the balloon length, balloon diameter and balloon wall thickness outside the typical ranges indicated above may be used, depending, inter alia, on the specific application for which the catheter is designed.
  • the outer perforated balloons of the catheters of the present application are capable of withstanding the forces exerted by the corresponding inner (drug coated) balloon used in the catheter when the inner balloon of the catheter is inflated to its nominal inflated diameter.
  • the outer perforated balloons may also increase the internal pressure the inner balloon can withstand by supporting (or reinforcing) the inner balloon when the inner balloon 4 is inflated.
  • This desirable reinforcing effect may be achieved by suitably selecting, inter alia, the wall thickness of the outer perforated balloon 6, and the mechanical properties of the material(s) from which the outer perforated balloon is made.
  • Typical dimensions of the outer perforated balloons of the catheters of the present application may be a balloon diameter in the range of 2-15 millimeters, a balloon length in the range of 8-300 millimeters and a balloon wall thickness in the range of 0.01-0.1 millimeter.
  • these ranges are by no means obligatory or limiting and other higher or lower values of the outer perforated balloon length, outer perforated balloon diameter and outer perforated balloon wall thickness outside the typical ranges indicated above may be used, depending, inter alia, on the specific application for which the catheter is designed.
  • the diameter of the outer perforated balloon in the fully expanded state and the diameter of the inner balloon at the nominal inflation pressure may be even larger than 15 millimeters (if treating large peripheral veins or the vena cava).
  • a stretchable (semi-compliant) outer perforated balloon with a highly compliant inner balloon such as, for example a Latex® balloon.
  • the inner inflatable drug coated balloon and/or the outer perforated balloon may be folded or not folded, as required by the application and by the circumference of the inner balloon and/or the outer perforated balloon when they are in the non-inflated state or in the non opened and/or non-unfolded state.
  • the length of the inner balloon may be equal to the length of the outer perforated balloon (see for an example the catheter 70 of Fig. 14), while in some other embodiments of the catheter, the length of the inner balloon may be smaller than the length of the outer perforated balloon (see the exemplary catheters 80 and 90 of Figs. 15 and 16, respectively and the exemplary catheters 200 300, 400 and 500 of Figs. 22, 23, 24 and 25, respectively).
  • the length of the inner balloon (as measured from the most distal end of the inner balloon to the most proximal end of the inner balloon) may be actually larger than the length of the outer perforated balloon (as measured from the most distal end of the outer perforated balloon to the most proximal end of the outer perforated balloon).
  • any of the drug delivery catheters disclosed in the present application may be inserted into the vasculature using any clinically acceptable entry point as is known in the art.
  • the catheter After insertion of the catheter (preferably over a guide wire), the catheter is navigated through the vasculature in a non-inflated or pre-inflated state to advantageously achieve protection against drug washout and to prevent or at least reduce any flakes or particles of the drug carrying formulation from entering the blood stream.
  • the inner balloon of the catheter may be inflated at the nominal inflation pressure to expand (and/or unfold, if relevant) the inner balloon.
  • the inner balloon may also radially expand and/or unfold, (if relevant) the outer perforated balloon by radially pushing the outer perforated balloon.
  • the pushing by the radially expanding inner balloon may either increase the area of the perforations and/or may uncover any perforations that were covered by regions of the outer perforated balloon (if the outer perforated balloon is folded).
  • the pushing by the radially expanding inner balloon may also result in both increasing the area of the perforations and uncovering previously covered perforations (such as, for example, in catheter embodiments with semi-compliant inner and outer perforated balloons having a folded outer perforated balloon, or in catheter embodiments with a compliant inner balloon and a compliant outer perforated balloon and a folded outer perforated balloon).
  • the expanded outer perforated balloon pushes the walls of the treated region and may open or enlarge the constricted lumen of the blood vessel and may also compress and/or compact the atheroma.
  • the drug or drugs may be applied to the treated region by exiting through the enlarged area of the perforations, facilitating drug transfer from the drug coated surface of the inner balloon to at least some regions of the treatment site.
  • this drug transfer to the treated region may be assisted by the protrusion of drug coated surface regions of the inner balloon which may bulge out of the perforations and may contact the walls of the treated region of the blood vessel when the inner balloon is inflated at the nominal inflation pressure.
  • the inflation of the inner balloon may also open and deploy the stent, as is well known in the art of angioplasty using stent carrying catheters.
  • the inner balloon may be deflated.
  • the inner balloon and the outer perforated balloon may radially contract, and the catheter may be withdrawn through the vasculature and removed from the body.
  • the above disclosed methods for using the drug delivery catheters of the present application may also include further steps in which the guide wire 3 may be removed (if a guide wire was being used in the method) from the lumen of the catheter into which it was inserted and a surgical tool and/or a diagnostic tool or any other assisting tools for angioplasty may be inserted into the same lumen and advanced towards the treated region to further treat or manipulate the target region if necessary.
  • a surgical tool and/or a diagnostic tool or any other assisting tools for angioplasty may be inserted into the same lumen and advanced towards the treated region to further treat or manipulate the target region if necessary.
  • Such tools may include, but are not limited to, a surgical blade, a snare, a rotablator, a surgical laser device, a laser-coupled optical fiber, an occluding inflatable balloon or any other surgical tools or assisting tools known in the art.
  • Diagnostic tools may include, but are not limited to, a camera, an infra-red camera or any other optical imaging tool, an ultrasonic imaging tool (IVUS), a miniature MRI tool for imaging blood vessel walls, a chemical sensor, and any other suitable diagnostic tool.
  • Such surgical tools and/or diagnostic tools and/or assisting tools may be inserted into the lumen of the catheter that is used for passage of a guide wire (after removing the guide wire) at any stage of use of the catheter, including, but not limited to, the stage in which the outer balloon is disposed in the target region but before inflation of the inner balloon of the catheter, the stage after the inner balloon is inflated at the nominal inflation pressure, or any other suitable stage of the operation of the catheter.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Un cathéter d'administration de médicament comprend un arbre, un ballonnet interne gonflable fixé à l'arbre. Le ballonnet gonflable a une surface externe revêtue d'un médicament ou d'une composition comprenant un médicament. Le cathéter comprend également un ballonnet externe perforé. Le ballonnet externe perforé entoure le ballonnet interne gonflable. Le ballonnet perforé présente de multiples perforations à l'intérieur de celui-ci. Un procédé d'administration d'un médicament au niveau d'un site traité à l'aide du cathéter comprend l'insertion du cathéter dans une cavité corporelle pour disposer le ballonnet externe perforé dans un site à traiter et le gonflage du ballonnet gonflable pour traiter le site et pour administrer le médicament à au moins certaines régions du site traité à travers les multiples perforations. La cavité corporelle peut être un vaisseau sanguin ou toute autre cavité corporelle.
PCT/IL2017/050911 2016-08-18 2017-08-17 Cathéter d'administration de médicament et son procédé d'utilisation WO2018033920A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662376439P 2016-08-18 2016-08-18
US62/376,439 2016-08-18

Publications (1)

Publication Number Publication Date
WO2018033920A1 true WO2018033920A1 (fr) 2018-02-22

Family

ID=61196506

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2017/050911 WO2018033920A1 (fr) 2016-08-18 2017-08-17 Cathéter d'administration de médicament et son procédé d'utilisation

Country Status (1)

Country Link
WO (1) WO2018033920A1 (fr)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10124153B2 (en) 2012-12-04 2018-11-13 Angioslide Ltd. Balloon catheter and methods of use thereof
CN112145746A (zh) * 2020-11-30 2020-12-29 上海微创医疗器械（集团）有限公司 驱动装置和旋磨设备
KR20210084589A (ko) * 2018-11-05 2021-07-07 상하이 마이크로포트 카디오플로우 메디테크 컴퍼니 리미티드 벌룬 팽창 카테터, 벌룬 및 그것들을 위한 준비 방법
CN113350648A (zh) * 2021-07-18 2021-09-07 温州医科大学附属第一医院 一种可准确局麻的气管导管
CN113427784A (zh) * 2021-06-29 2021-09-24 伊索曼(中山)医疗器械有限公司 医用球囊表面凸起的制作方法及医用球囊
CN114098899A (zh) * 2021-11-04 2022-03-01 杭州天路医疗器械有限公司 非封闭式球囊的冲击波导管及其制备工艺、定向送药方法
CN114514046A (zh) * 2019-07-31 2022-05-17 奥卢森特生物医学公司 用于修复组织的装置和方法
EP4085855A1 (fr) * 2021-05-04 2022-11-09 Hemosquid Dispositif hémostatique
WO2022233895A1 (fr) * 2021-05-04 2022-11-10 Hemosquid Dispositif hémostatique
US11648392B2 (en) 2016-11-23 2023-05-16 Magenta Medical Ltd. Blood pumps
US11648387B2 (en) 2015-05-18 2023-05-16 Magenta Medical Ltd. Blood pump
US11648391B2 (en) 2013-03-13 2023-05-16 Magenta Medical Ltd. Blood pump
US11666747B2 (en) 2019-01-24 2023-06-06 Magenta Medical Ltd. Manufacturing an impeller
US11684275B2 (en) 2018-01-10 2023-06-27 Magenta Medical Ltd. Distal tip element for blood pump
US11839540B2 (en) 2012-06-06 2023-12-12 Magenta Medical Ltd Vena-caval apparatus and methods
US11839754B2 (en) 2016-10-25 2023-12-12 Magenta Medical Ltd Ventricular assist device
US11883274B2 (en) 2013-03-13 2024-01-30 Magenta Medical Ltd. Vena-caval blood pump

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100069900A1 (en) * 2008-09-18 2010-03-18 Cook Incorporated Dual balloon catheter assembly
US20120143054A1 (en) * 2009-04-13 2012-06-07 Eaton Elizabeth A Coated balloon catheter
US20150306361A1 (en) * 2012-12-04 2015-10-29 Angioslide Ltd Balloon catheter and methods of use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100069900A1 (en) * 2008-09-18 2010-03-18 Cook Incorporated Dual balloon catheter assembly
US20120143054A1 (en) * 2009-04-13 2012-06-07 Eaton Elizabeth A Coated balloon catheter
US20150306361A1 (en) * 2012-12-04 2015-10-29 Angioslide Ltd Balloon catheter and methods of use thereof

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11839540B2 (en) 2012-06-06 2023-12-12 Magenta Medical Ltd Vena-caval apparatus and methods
US10124153B2 (en) 2012-12-04 2018-11-13 Angioslide Ltd. Balloon catheter and methods of use thereof
US11883274B2 (en) 2013-03-13 2024-01-30 Magenta Medical Ltd. Vena-caval blood pump
US11850415B2 (en) 2013-03-13 2023-12-26 Magenta Medical Ltd. Blood pump
US11648391B2 (en) 2013-03-13 2023-05-16 Magenta Medical Ltd. Blood pump
US11648387B2 (en) 2015-05-18 2023-05-16 Magenta Medical Ltd. Blood pump
US11839754B2 (en) 2016-10-25 2023-12-12 Magenta Medical Ltd Ventricular assist device
US11648392B2 (en) 2016-11-23 2023-05-16 Magenta Medical Ltd. Blood pumps
US11844592B2 (en) 2018-01-10 2023-12-19 Magenta Medical Ltd. Impeller and frame for blood pump
US11684275B2 (en) 2018-01-10 2023-06-27 Magenta Medical Ltd. Distal tip element for blood pump
US11950889B2 (en) 2018-01-10 2024-04-09 Magenta Medical Ltd. Ventricular assist device
US11944413B2 (en) 2018-01-10 2024-04-02 Magenta Medical Ltd. Ventricular assist device
US11806116B2 (en) 2018-01-10 2023-11-07 Magenta Medical Ltd. Sensor for blood pump
US11806117B2 (en) 2018-01-10 2023-11-07 Magenta Medical Ltd. Drive cable for blood pump
US11690521B2 (en) 2018-01-10 2023-07-04 Magenta Medical Ltd. Impeller for blood pump
EP3871730A4 (fr) * 2018-11-05 2022-01-05 Shanghai Microport Cardioflow Medtech Co., Ltd. Cathéter à ballonnet de dilatation, ballonnet et procédé de préparation
KR102600243B1 (ko) * 2018-11-05 2023-11-09 상하이 마이크로포트 카디오플로우 메디테크 컴퍼니 리미티드 벌룬 팽창 카테터, 벌룬 및 그것들을 위한 준비 방법
KR20210084589A (ko) * 2018-11-05 2021-07-07 상하이 마이크로포트 카디오플로우 메디테크 컴퍼니 리미티드 벌룬 팽창 카테터, 벌룬 및 그것들을 위한 준비 방법
US11964143B2 (en) 2019-01-24 2024-04-23 Magenta Medical Ltd. Flexible drive cable with rigid axial shaft
US11944800B2 (en) 2019-01-24 2024-04-02 Magenta Medical Ltd. Atraumatic balloon for blood pump
US11666747B2 (en) 2019-01-24 2023-06-06 Magenta Medical Ltd. Manufacturing an impeller
CN114514046A (zh) * 2019-07-31 2022-05-17 奥卢森特生物医学公司 用于修复组织的装置和方法
CN114514046B (zh) * 2019-07-31 2024-03-08 奥卢森特生物医学公司 用于修复组织的装置和方法
CN112145746B (zh) * 2020-11-30 2021-03-23 上海微创医疗器械（集团）有限公司 驱动装置和旋磨设备
CN112145746A (zh) * 2020-11-30 2020-12-29 上海微创医疗器械（集团）有限公司 驱动装置和旋磨设备
WO2022233895A1 (fr) * 2021-05-04 2022-11-10 Hemosquid Dispositif hémostatique
EP4085855A1 (fr) * 2021-05-04 2022-11-09 Hemosquid Dispositif hémostatique
CN113427784A (zh) * 2021-06-29 2021-09-24 伊索曼(中山)医疗器械有限公司 医用球囊表面凸起的制作方法及医用球囊
CN113427784B (zh) * 2021-06-29 2022-09-13 伊索曼(中山)医疗器械有限公司 医用球囊表面凸起的制作方法及医用球囊
CN113350648A (zh) * 2021-07-18 2021-09-07 温州医科大学附属第一医院 一种可准确局麻的气管导管
CN114098899A (zh) * 2021-11-04 2022-03-01 杭州天路医疗器械有限公司 非封闭式球囊的冲击波导管及其制备工艺、定向送药方法
CN114098899B (zh) * 2021-11-04 2023-11-03 杭州天路医疗器械有限公司 非封闭式球囊的冲击波导管及其制备工艺、定向送药方法

Similar Documents

Publication Publication Date Title
WO2018033920A1 (fr) Cathéter d'administration de médicament et son procédé d'utilisation
CN107308536B (zh) 包括药物输送护套的球囊导管
CN109414528B (zh) 用于体腔的药物涂布球囊导管
AU2013312748B2 (en) Retractable sheath devices, systems, and methods
US7658744B2 (en) Multiple balloon catheter
US20100228333A1 (en) Drug eluting surface covering
US7108684B2 (en) Drug delivery balloon catheter
US6491711B1 (en) Balloon catheter with non-circular balloon taper and method of use
US9327101B2 (en) Length and diameter adjustable balloon catheter
ES2743929T3 (es) Cierre hermético con anillo pivotante
EP2898920B1 (fr) Cathéter à ballonnet articulé
US20080221552A1 (en) Agent delivery perfusion catheter
CN113727750A (zh) 用于体腔的药物涂布的球囊导管
JP2010537680A (ja) 最小限に侵略可能な血管内処理装置
WO2001085247A1 (fr) Catheter a ballonnet lobe et procede d'utilisation
WO1995026776A1 (fr) Catheter pour delivrer des agents therapeutiques
JP2010273936A (ja) バルーンカテーテル
JP2022509927A (ja) デュアルバルーンカテーテル及びその使用方法
US20200282188A1 (en) Drug layer applying device and method for forming drug layer
JPH0833720A (ja) 血管内投薬用バルーンカテーテル
CN215690913U (zh) 一种自灌注药物洗脱球囊及自灌注药物洗脱器械
JP7357047B2 (ja) バルーンカテーテルおよびバルーン配置方法
US20200276421A1 (en) Drug layer applying device and method for forming drug layer
CN113577512A (zh) 一种自灌注药物洗脱球囊及自灌注药物洗脱器械
JPH08187291A (ja) ポーラスバルーンカテーテル

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17841219

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17841219

Country of ref document: EP

Kind code of ref document: A1